id	sid	tid	token	lemma	pos
cord-258230-s4ty52kb	1	1	key	key	JJ
cord-258230-s4ty52kb	1	2	:	:	:
cord-258230-s4ty52kb	1	3	cord-258230-s4ty52	cord-258230-s4ty52	JJ
cord-258230-s4ty52kb	1	4	kb	kb	NNP
cord-258230-s4ty52kb	1	5	authors	author	NNS
cord-258230-s4ty52kb	1	6	:	:	:
cord-258230-s4ty52kb	1	7	Grover	Grover	NNP
cord-258230-s4ty52kb	1	8	,	,	,
cord-258230-s4ty52kb	1	9	Abhinav	Abhinav	NNP
cord-258230-s4ty52kb	1	10	;	;	:
cord-258230-s4ty52kb	1	11	Oberoi	Oberoi	NNP
cord-258230-s4ty52kb	1	12	,	,	,
cord-258230-s4ty52kb	1	13	Mansi	Mansi	NNP
cord-258230-s4ty52kb	1	14	title	title	NN
cord-258230-s4ty52kb	1	15	:	:	:
cord-258230-s4ty52kb	2	1	A	a	DT
cord-258230-s4ty52kb	2	2	systematic	systematic	JJ
cord-258230-s4ty52kb	2	3	review	review	NN
cord-258230-s4ty52kb	2	4	and	and	CC
cord-258230-s4ty52kb	2	5	meta	meta	NNP
cord-258230-s4ty52kb	2	6	-	-	HYPH
cord-258230-s4ty52kb	2	7	analysis	analysis	NN
cord-258230-s4ty52kb	2	8	to	to	TO
cord-258230-s4ty52kb	2	9	evaluate	evaluate	VB
cord-258230-s4ty52kb	2	10	the	the	DT
cord-258230-s4ty52kb	2	11	clinical	clinical	JJ
cord-258230-s4ty52kb	2	12	outcomes	outcome	NNS
cord-258230-s4ty52kb	2	13	in	in	IN
cord-258230-s4ty52kb	2	14	COVID-19	covid-19	JJ
cord-258230-s4ty52kb	2	15	patients	patient	NNS
cord-258230-s4ty52kb	2	16	on	on	IN
cord-258230-s4ty52kb	2	17	angiotensin	angiotensin	NN
cord-258230-s4ty52kb	2	18	-	-	HYPH
cord-258230-s4ty52kb	2	19	converting	convert	VBG
cord-258230-s4ty52kb	2	20	enzyme	enzyme	NN
cord-258230-s4ty52kb	2	21	inhibitors	inhibitor	NNS
cord-258230-s4ty52kb	2	22	or	or	CC
cord-258230-s4ty52kb	2	23	angiotensin	angiotensin	NN
cord-258230-s4ty52kb	2	24	receptor	receptor	NN
cord-258230-s4ty52kb	2	25	blockers	blocker	NNS
cord-258230-s4ty52kb	2	26	date	date	NN
cord-258230-s4ty52kb	2	27	:	:	:
cord-258230-s4ty52kb	2	28	2020	2020	CD
cord-258230-s4ty52kb	2	29	-	-	HYPH
cord-258230-s4ty52kb	2	30	06	06	CD
cord-258230-s4ty52kb	2	31	-	-	SYM
cord-258230-s4ty52kb	2	32	15	15	CD
cord-258230-s4ty52kb	2	33	journal	journal	NN
cord-258230-s4ty52kb	2	34	:	:	:
cord-258230-s4ty52kb	3	1	Eur	Eur	NNP
cord-258230-s4ty52kb	3	2	Heart	Heart	NNP
cord-258230-s4ty52kb	3	3	J	J	NNP
cord-258230-s4ty52kb	3	4	Cardiovasc	Cardiovasc	NNP
cord-258230-s4ty52kb	3	5	Pharmacother	Pharmacother	NNP
cord-258230-s4ty52kb	3	6	DOI	DOI	NNP
cord-258230-s4ty52kb	3	7	:	:	:
cord-258230-s4ty52kb	4	1	10.1093	10.1093	CD
cord-258230-s4ty52kb	4	2	/	/	SYM
cord-258230-s4ty52kb	4	3	ehjcvp	ehjcvp	NNP
cord-258230-s4ty52kb	4	4	/	/	SYM
cord-258230-s4ty52kb	4	5	pvaa064	pvaa064	NNP
cord-258230-s4ty52kb	4	6	sha	sha	NNP
cord-258230-s4ty52kb	4	7	:	:	:
cord-258230-s4ty52kb	4	8	596cabaca1105d86b0f878ce55763541f10ec469	596cabaca1105d86b0f878ce55763541f10ec469	CD
cord-258230-s4ty52kb	4	9	doc_id	doc_id	CD
cord-258230-s4ty52kb	4	10	:	:	:
cord-258230-s4ty52kb	4	11	258230	258230	CD
cord-258230-s4ty52kb	4	12	cord_uid	cord_uid	NNS
cord-258230-s4ty52kb	4	13	:	:	:
cord-258230-s4ty52kb	5	1	s4ty52	s4ty52	NNP
cord-258230-s4ty52kb	6	1	kb	kb	NNP
cord-258230-s4ty52kb	6	2	INTRODUCTION	INTRODUCTION	NNP
cord-258230-s4ty52kb	6	3	:	:	:
cord-258230-s4ty52kb	7	1	Angiotensin	angiotensin	NN
cord-258230-s4ty52kb	7	2	-	-	HYPH
cord-258230-s4ty52kb	7	3	converting	convert	VBG
cord-258230-s4ty52kb	7	4	enzyme	enzyme	NN
cord-258230-s4ty52kb	7	5	inhibitors	inhibitor	NNS
cord-258230-s4ty52kb	7	6	(	(	-LRB-
cord-258230-s4ty52kb	7	7	ACEIs	acei	NNS
cord-258230-s4ty52kb	7	8	)	)	-RRB-
cord-258230-s4ty52kb	7	9	and	and	CC
cord-258230-s4ty52kb	7	10	angiotensin	angiotensin	NN
cord-258230-s4ty52kb	7	11	receptor	receptor	NN
cord-258230-s4ty52kb	7	12	blockers	blocker	NNS
cord-258230-s4ty52kb	7	13	(	(	-LRB-
cord-258230-s4ty52kb	7	14	ARBs	arb	NNS
cord-258230-s4ty52kb	7	15	)	)	-RRB-
cord-258230-s4ty52kb	7	16	share	share	VBP
cord-258230-s4ty52kb	7	17	their	-PRON-	PRP$
cord-258230-s4ty52kb	7	18	target	target	NN
cord-258230-s4ty52kb	7	19	receptor	receptor	NN
cord-258230-s4ty52kb	7	20	site	site	NN
cord-258230-s4ty52kb	7	21	with	with	IN
cord-258230-s4ty52kb	7	22	the	the	DT
cord-258230-s4ty52kb	7	23	SARS	SARS	NNP
cord-258230-s4ty52kb	7	24	-	-	HYPH
cord-258230-s4ty52kb	7	25	CoV-2	CoV-2	NNP
cord-258230-s4ty52kb	7	26	virus	virus	NN
cord-258230-s4ty52kb	7	27	,	,	,
cord-258230-s4ty52kb	7	28	that	that	WDT
cord-258230-s4ty52kb	7	29	may	may	MD
cord-258230-s4ty52kb	7	30	cause	cause	VB
cord-258230-s4ty52kb	7	31	ACE2	ACE2	NNP
cord-258230-s4ty52kb	7	32	receptor	receptor	NN
cord-258230-s4ty52kb	7	33	up	up	IN
cord-258230-s4ty52kb	7	34	-	-	HYPH
cord-258230-s4ty52kb	7	35	regulation	regulation	NN
cord-258230-s4ty52kb	7	36	which	which	WDT
cord-258230-s4ty52kb	7	37	raised	raise	VBD
cord-258230-s4ty52kb	7	38	concerns	concern	NNS
cord-258230-s4ty52kb	7	39	regarding	regard	VBG
cord-258230-s4ty52kb	7	40	ACEI	ACEI	NNP
cord-258230-s4ty52kb	7	41	and	and	CC
cord-258230-s4ty52kb	7	42	ARB	ARB	NNP
cord-258230-s4ty52kb	7	43	use	use	NN
cord-258230-s4ty52kb	7	44	in	in	IN
cord-258230-s4ty52kb	7	45	COVID-19	covid-19	JJ
cord-258230-s4ty52kb	7	46	patients	patient	NNS
cord-258230-s4ty52kb	7	47	.	.	.
cord-258230-s4ty52kb	8	1	However	however	RB
cord-258230-s4ty52kb	8	2	,	,	,
cord-258230-s4ty52kb	8	3	many	many	JJ
cord-258230-s4ty52kb	8	4	medical	medical	JJ
cord-258230-s4ty52kb	8	5	professional	professional	JJ
cord-258230-s4ty52kb	8	6	societies	society	NNS
cord-258230-s4ty52kb	8	7	recommended	recommend	VBD
cord-258230-s4ty52kb	8	8	their	-PRON-	PRP$
cord-258230-s4ty52kb	8	9	continued	continue	VBN
cord-258230-s4ty52kb	8	10	use	use	NN
cord-258230-s4ty52kb	8	11	given	give	VBN
cord-258230-s4ty52kb	8	12	the	the	DT
cord-258230-s4ty52kb	8	13	paucity	paucity	NN
cord-258230-s4ty52kb	8	14	of	of	IN
cord-258230-s4ty52kb	8	15	clinical	clinical	JJ
cord-258230-s4ty52kb	8	16	evidence	evidence	NN
cord-258230-s4ty52kb	8	17	,	,	,
cord-258230-s4ty52kb	8	18	but	but	CC
cord-258230-s4ty52kb	8	19	there	there	EX
cord-258230-s4ty52kb	8	20	is	be	VBZ
cord-258230-s4ty52kb	8	21	a	a	DT
cord-258230-s4ty52kb	8	22	need	need	NN
cord-258230-s4ty52kb	8	23	for	for	IN
cord-258230-s4ty52kb	8	24	an	an	DT
cord-258230-s4ty52kb	8	25	updated	update	VBN
cord-258230-s4ty52kb	8	26	systematic	systematic	JJ
cord-258230-s4ty52kb	8	27	review	review	NN
cord-258230-s4ty52kb	8	28	and	and	CC
cord-258230-s4ty52kb	8	29	meta	meta	NNP
cord-258230-s4ty52kb	8	30	-	-	HYPH
cord-258230-s4ty52kb	8	31	analysis	analysis	NN
cord-258230-s4ty52kb	8	32	of	of	IN
cord-258230-s4ty52kb	8	33	the	the	DT
cord-258230-s4ty52kb	8	34	latest	late	JJS
cord-258230-s4ty52kb	8	35	clinical	clinical	JJ
cord-258230-s4ty52kb	8	36	studies	study	NNS
cord-258230-s4ty52kb	8	37	.	.	.
cord-258230-s4ty52kb	9	1	METHODS	method	NNS
cord-258230-s4ty52kb	9	2	AND	and	CC
cord-258230-s4ty52kb	9	3	RESULTS	result	NNS
cord-258230-s4ty52kb	9	4	:	:	:
cord-258230-s4ty52kb	10	1	A	a	DT
cord-258230-s4ty52kb	10	2	search	search	NN
cord-258230-s4ty52kb	10	3	was	be	VBD
cord-258230-s4ty52kb	10	4	conducted	conduct	VBN
cord-258230-s4ty52kb	10	5	on	on	IN
cord-258230-s4ty52kb	10	6	PubMed	PubMed	NNP
cord-258230-s4ty52kb	10	7	,	,	,
cord-258230-s4ty52kb	10	8	Google	Google	NNP
cord-258230-s4ty52kb	10	9	Scholar	Scholar	NNP
cord-258230-s4ty52kb	10	10	,	,	,
cord-258230-s4ty52kb	10	11	EMBASE	EMBASE	NNP
cord-258230-s4ty52kb	10	12	,	,	,
cord-258230-s4ty52kb	10	13	and	and	CC
cord-258230-s4ty52kb	10	14	various	various	JJ
cord-258230-s4ty52kb	10	15	preprint	preprint	NN
cord-258230-s4ty52kb	10	16	servers	server	NNS
cord-258230-s4ty52kb	10	17	for	for	IN
cord-258230-s4ty52kb	10	18	studies	study	NNS
cord-258230-s4ty52kb	10	19	comparing	compare	VBG
cord-258230-s4ty52kb	10	20	clinical	clinical	JJ
cord-258230-s4ty52kb	10	21	outcomes	outcome	NNS
cord-258230-s4ty52kb	10	22	and	and	CC
cord-258230-s4ty52kb	10	23	mortality	mortality	NN
cord-258230-s4ty52kb	10	24	in	in	IN
cord-258230-s4ty52kb	10	25	COVID-19	covid-19	JJ
cord-258230-s4ty52kb	10	26	patients	patient	NNS
cord-258230-s4ty52kb	10	27	on	on	IN
cord-258230-s4ty52kb	10	28	ACEIs	acei	NNS
cord-258230-s4ty52kb	10	29	and/or	and/or	CC
cord-258230-s4ty52kb	10	30	ARBs	arb	NNS
cord-258230-s4ty52kb	10	31	,	,	,
cord-258230-s4ty52kb	10	32	and	and	CC
cord-258230-s4ty52kb	10	33	a	a	DT
cord-258230-s4ty52kb	10	34	meta	meta	JJ
cord-258230-s4ty52kb	10	35	-	-	HYPH
cord-258230-s4ty52kb	10	36	analysis	analysis	NN
cord-258230-s4ty52kb	10	37	was	be	VBD
cord-258230-s4ty52kb	10	38	performed	perform	VBN
cord-258230-s4ty52kb	10	39	.	.	.
cord-258230-s4ty52kb	11	1	A	a	DT
cord-258230-s4ty52kb	11	2	total	total	NN
cord-258230-s4ty52kb	11	3	of	of	IN
cord-258230-s4ty52kb	11	4	16	16	CD
cord-258230-s4ty52kb	11	5	studies	study	NNS
cord-258230-s4ty52kb	11	6	were	be	VBD
cord-258230-s4ty52kb	11	7	included	include	VBN
cord-258230-s4ty52kb	11	8	for	for	IN
cord-258230-s4ty52kb	11	9	the	the	DT
cord-258230-s4ty52kb	11	10	review	review	NN
cord-258230-s4ty52kb	11	11	and	and	CC
cord-258230-s4ty52kb	11	12	meta	meta	NNP
cord-258230-s4ty52kb	11	13	-	-	HYPH
cord-258230-s4ty52kb	11	14	analysis	analysis	NN
cord-258230-s4ty52kb	11	15	.	.	.
cord-258230-s4ty52kb	12	1	There	there	EX
cord-258230-s4ty52kb	12	2	were	be	VBD
cord-258230-s4ty52kb	12	3	conflicting	conflict	VBG
cord-258230-s4ty52kb	12	4	findings	finding	NNS
cord-258230-s4ty52kb	12	5	reported	report	VBN
cord-258230-s4ty52kb	12	6	in	in	IN
cord-258230-s4ty52kb	12	7	the	the	DT
cord-258230-s4ty52kb	12	8	rates	rate	NNS
cord-258230-s4ty52kb	12	9	of	of	IN
cord-258230-s4ty52kb	12	10	severity	severity	NN
cord-258230-s4ty52kb	12	11	and	and	CC
cord-258230-s4ty52kb	12	12	mortality	mortality	NN
cord-258230-s4ty52kb	12	13	in	in	IN
cord-258230-s4ty52kb	12	14	several	several	JJ
cord-258230-s4ty52kb	12	15	studies	study	NNS
cord-258230-s4ty52kb	12	16	.	.	.
cord-258230-s4ty52kb	13	1	In	in	IN
cord-258230-s4ty52kb	13	2	a	a	DT
cord-258230-s4ty52kb	13	3	pooled	pool	VBN
cord-258230-s4ty52kb	13	4	analysis	analysis	NN
cord-258230-s4ty52kb	13	5	of	of	IN
cord-258230-s4ty52kb	13	6	four	four	CD
cord-258230-s4ty52kb	13	7	studies	study	NNS
cord-258230-s4ty52kb	13	8	,	,	,
cord-258230-s4ty52kb	13	9	there	there	EX
cord-258230-s4ty52kb	13	10	was	be	VBD
cord-258230-s4ty52kb	13	11	a	a	DT
cord-258230-s4ty52kb	13	12	statistically	statistically	RB
cord-258230-s4ty52kb	13	13	non	non	JJ
cord-258230-s4ty52kb	13	14	-	-	JJ
cord-258230-s4ty52kb	13	15	significant	significant	JJ
cord-258230-s4ty52kb	13	16	association	association	NN
cord-258230-s4ty52kb	13	17	of	of	IN
cord-258230-s4ty52kb	13	18	ACEI	ACEI	NNP
cord-258230-s4ty52kb	13	19	/	/	SYM
cord-258230-s4ty52kb	13	20	ARB	ARB	NNP
cord-258230-s4ty52kb	13	21	use	use	NN
cord-258230-s4ty52kb	13	22	with	with	IN
cord-258230-s4ty52kb	13	23	lower	low	JJR
cord-258230-s4ty52kb	13	24	odds	odd	NNS
cord-258230-s4ty52kb	13	25	of	of	IN
cord-258230-s4ty52kb	13	26	developing	develop	VBG
cord-258230-s4ty52kb	13	27	severe	severe	JJ
cord-258230-s4ty52kb	13	28	disease	disease	NN
cord-258230-s4ty52kb	13	29	vs.	vs.	FW
cord-258230-s4ty52kb	13	30	non	non	NNS
cord-258230-s4ty52kb	13	31	-	-	NNS
cord-258230-s4ty52kb	13	32	users	user	NNS
cord-258230-s4ty52kb	13	33	[	[	-LRB-
cord-258230-s4ty52kb	13	34	odds	odd	NNS
cord-258230-s4ty52kb	13	35	ratio	ratio	NN
cord-258230-s4ty52kb	13	36	(	(	-LRB-
cord-258230-s4ty52kb	13	37	OR	OR	NNP
cord-258230-s4ty52kb	13	38	)	)	-RRB-
cord-258230-s4ty52kb	13	39	=	=	SYM
cord-258230-s4ty52kb	13	40	0.81	0.81	CD
cord-258230-s4ty52kb	13	41	,	,	,
cord-258230-s4ty52kb	13	42	95	95	CD
cord-258230-s4ty52kb	13	43	%	%	NN
cord-258230-s4ty52kb	13	44	confidence	confidence	NN
cord-258230-s4ty52kb	13	45	interval	interval	NN
cord-258230-s4ty52kb	13	46	(	(	-LRB-
cord-258230-s4ty52kb	13	47	CI	ci	NN
cord-258230-s4ty52kb	13	48	)	)	-RRB-
cord-258230-s4ty52kb	13	49	:	:	:
cord-258230-s4ty52kb	13	50	0.41–1.58	0.41–1.58	NNP
cord-258230-s4ty52kb	13	51	,	,	,
cord-258230-s4ty52kb	13	52	I(2)=50.52	I(2)=50.52	NNP
cord-258230-s4ty52kb	13	53	,	,	,
cord-258230-s4ty52kb	13	54	P	p	NN
cord-258230-s4ty52kb	13	55	-	-	HYPH
cord-258230-s4ty52kb	13	56	value	value	NN
cord-258230-s4ty52kb	13	57	=	=	SYM
cord-258230-s4ty52kb	13	58	0.53	0.53	CD
cord-258230-s4ty52kb	13	59	)	)	-RRB-
cord-258230-s4ty52kb	13	60	.	.	.
cord-258230-s4ty52kb	14	1	In	in	IN
cord-258230-s4ty52kb	14	2	a	a	DT
cord-258230-s4ty52kb	14	3	pooled	pool	VBN
cord-258230-s4ty52kb	14	4	analysis	analysis	NN
cord-258230-s4ty52kb	14	5	of	of	IN
cord-258230-s4ty52kb	14	6	six	six	CD
cord-258230-s4ty52kb	14	7	studies	study	NNS
cord-258230-s4ty52kb	14	8	,	,	,
cord-258230-s4ty52kb	14	9	there	there	EX
cord-258230-s4ty52kb	14	10	was	be	VBD
cord-258230-s4ty52kb	14	11	a	a	DT
cord-258230-s4ty52kb	14	12	statistically	statistically	RB
cord-258230-s4ty52kb	14	13	non	non	JJ
cord-258230-s4ty52kb	14	14	-	-	JJ
cord-258230-s4ty52kb	14	15	significant	significant	JJ
cord-258230-s4ty52kb	14	16	association	association	NN
cord-258230-s4ty52kb	14	17	of	of	IN
cord-258230-s4ty52kb	14	18	ACEI	ACEI	NNP
cord-258230-s4ty52kb	14	19	/	/	SYM
cord-258230-s4ty52kb	14	20	ARB	ARB	NNP
cord-258230-s4ty52kb	14	21	use	use	NN
cord-258230-s4ty52kb	14	22	with	with	IN
cord-258230-s4ty52kb	14	23	lower	low	JJR
cord-258230-s4ty52kb	14	24	odds	odd	NNS
cord-258230-s4ty52kb	14	25	of	of	IN
cord-258230-s4ty52kb	14	26	mortality	mortality	NN
cord-258230-s4ty52kb	14	27	as	as	IN
cord-258230-s4ty52kb	14	28	compared	compare	VBN
cord-258230-s4ty52kb	14	29	with	with	IN
cord-258230-s4ty52kb	14	30	non	non	NNS
cord-258230-s4ty52kb	14	31	-	-	NNS
cord-258230-s4ty52kb	14	32	users	user	NNS
cord-258230-s4ty52kb	14	33	(	(	-LRB-
cord-258230-s4ty52kb	14	34	OR	or	CC
cord-258230-s4ty52kb	14	35	=	=	SYM
cord-258230-s4ty52kb	14	36	0.86	0.86	CD
cord-258230-s4ty52kb	14	37	,	,	,
cord-258230-s4ty52kb	14	38	95	95	CD
cord-258230-s4ty52kb	14	39	%	%	NN
cord-258230-s4ty52kb	14	40	CI	ci	NN
cord-258230-s4ty52kb	14	41	=	=	SYM
cord-258230-s4ty52kb	14	42	0.53–1.41	0.53–1.41	NNP
cord-258230-s4ty52kb	14	43	,	,	,
cord-258230-s4ty52kb	14	44	I(2	I(2	NNP
cord-258230-s4ty52kb	14	45	)	)	-RRB-
cord-258230-s4ty52kb	14	46	=	=	NFP
cord-258230-s4ty52kb	15	1	79.12	79.12	CD
cord-258230-s4ty52kb	15	2	,	,	,
cord-258230-s4ty52kb	15	3	P	p	NN
cord-258230-s4ty52kb	15	4	-	-	HYPH
cord-258230-s4ty52kb	15	5	value	value	NN
cord-258230-s4ty52kb	15	6	=	=	SYM
cord-258230-s4ty52kb	15	7	0.55	0.55	CD
cord-258230-s4ty52kb	15	8	)	)	-RRB-
cord-258230-s4ty52kb	15	9	.	.	.
cord-258230-s4ty52kb	16	1	CONCLUSION	conclusion	NN
cord-258230-s4ty52kb	16	2	:	:	:
cord-258230-s4ty52kb	17	1	It	-PRON-	PRP
cord-258230-s4ty52kb	17	2	is	be	VBZ
cord-258230-s4ty52kb	17	3	concluded	conclude	VBN
cord-258230-s4ty52kb	17	4	that	that	IN
cord-258230-s4ty52kb	17	5	ACEIs	acei	NNS
cord-258230-s4ty52kb	17	6	and	and	CC
cord-258230-s4ty52kb	17	7	ARBs	arb	NNS
cord-258230-s4ty52kb	17	8	should	should	MD
cord-258230-s4ty52kb	17	9	be	be	VB
cord-258230-s4ty52kb	17	10	continued	continue	VBN
cord-258230-s4ty52kb	17	11	in	in	IN
cord-258230-s4ty52kb	17	12	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	17	13	patients	patient	NNS
cord-258230-s4ty52kb	17	14	,	,	,
cord-258230-s4ty52kb	17	15	reinforcing	reinforce	VBG
cord-258230-s4ty52kb	17	16	the	the	DT
cord-258230-s4ty52kb	17	17	recommendations	recommendation	NNS
cord-258230-s4ty52kb	17	18	made	make	VBN
cord-258230-s4ty52kb	17	19	by	by	IN
cord-258230-s4ty52kb	17	20	several	several	JJ
cord-258230-s4ty52kb	17	21	medical	medical	JJ
cord-258230-s4ty52kb	17	22	societies	society	NNS
cord-258230-s4ty52kb	17	23	.	.	.
cord-258230-s4ty52kb	18	1	Additionally	additionally	RB
cord-258230-s4ty52kb	18	2	,	,	,
cord-258230-s4ty52kb	18	3	the	the	DT
cord-258230-s4ty52kb	18	4	individual	individual	JJ
cord-258230-s4ty52kb	18	5	patient	patient	NN
cord-258230-s4ty52kb	18	6	factors	factor	NNS
cord-258230-s4ty52kb	18	7	such	such	JJ
cord-258230-s4ty52kb	18	8	as	as	IN
cord-258230-s4ty52kb	18	9	ACE2	ACE2	NNP
cord-258230-s4ty52kb	18	10	polymorphisms	polymorphism	NNS
cord-258230-s4ty52kb	18	11	which	which	WDT
cord-258230-s4ty52kb	18	12	might	may	MD
cord-258230-s4ty52kb	18	13	confer	confer	VB
cord-258230-s4ty52kb	18	14	higher	high	JJR
cord-258230-s4ty52kb	18	15	risk	risk	NN
cord-258230-s4ty52kb	18	16	of	of	IN
cord-258230-s4ty52kb	18	17	adverse	adverse	JJ
cord-258230-s4ty52kb	18	18	outcomes	outcome	NNS
cord-258230-s4ty52kb	18	19	need	need	VBP
cord-258230-s4ty52kb	18	20	to	to	TO
cord-258230-s4ty52kb	18	21	be	be	VB
cord-258230-s4ty52kb	18	22	evaluated	evaluate	VBN
cord-258230-s4ty52kb	18	23	further	further	RB
cord-258230-s4ty52kb	18	24	.	.	.
cord-258230-s4ty52kb	19	1	Severe	severe	JJ
cord-258230-s4ty52kb	19	2	acute	acute	JJ
cord-258230-s4ty52kb	19	3	respiratory	respiratory	JJ
cord-258230-s4ty52kb	19	4	syndrome	syndrome	NN
cord-258230-s4ty52kb	19	5	coronavirus	coronavirus	NN
cord-258230-s4ty52kb	19	6	2	2	CD
cord-258230-s4ty52kb	20	1	(	(	-LRB-
cord-258230-s4ty52kb	20	2	SARS	SARS	NNP
cord-258230-s4ty52kb	20	3	-	-	HYPH
cord-258230-s4ty52kb	20	4	COV2	COV2	NNP
cord-258230-s4ty52kb	20	5	)	)	-RRB-
cord-258230-s4ty52kb	20	6	causes	cause	VBZ
cord-258230-s4ty52kb	20	7	coronavirus	coronavirus	NN
cord-258230-s4ty52kb	20	8	disease	disease	NN
cord-258230-s4ty52kb	20	9	(	(	-LRB-
cord-258230-s4ty52kb	20	10	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	20	11	)	)	-RRB-
cord-258230-s4ty52kb	20	12	,	,	,
cord-258230-s4ty52kb	20	13	a	a	DT
cord-258230-s4ty52kb	20	14	potentially	potentially	RB
cord-258230-s4ty52kb	20	15	fatal	fatal	JJ
cord-258230-s4ty52kb	20	16	disease	disease	NN
cord-258230-s4ty52kb	20	17	that	that	WDT
cord-258230-s4ty52kb	20	18	is	be	VBZ
cord-258230-s4ty52kb	20	19	of	of	IN
cord-258230-s4ty52kb	20	20	immense	immense	JJ
cord-258230-s4ty52kb	20	21	global	global	JJ
cord-258230-s4ty52kb	20	22	public	public	JJ
cord-258230-s4ty52kb	20	23	health	health	NN
cord-258230-s4ty52kb	20	24	concern	concern	NN
cord-258230-s4ty52kb	20	25	.	.	.
cord-258230-s4ty52kb	21	1	The	the	DT
cord-258230-s4ty52kb	21	2	initial	initial	JJ
cord-258230-s4ty52kb	21	3	cases	case	NNS
cord-258230-s4ty52kb	21	4	were	be	VBD
cord-258230-s4ty52kb	21	5	reported	report	VBN
cord-258230-s4ty52kb	21	6	in	in	IN
cord-258230-s4ty52kb	21	7	December	December	NNP
cord-258230-s4ty52kb	21	8	2019	2019	CD
cord-258230-s4ty52kb	21	9	in	in	IN
cord-258230-s4ty52kb	21	10	Wuhan	Wuhan	NNP
cord-258230-s4ty52kb	21	11	,	,	,
cord-258230-s4ty52kb	21	12	China	China	NNP
cord-258230-s4ty52kb	21	13	.	.	.
cord-258230-s4ty52kb	22	1	1	1	LS
cord-258230-s4ty52kb	23	1	Since	since	IN
cord-258230-s4ty52kb	23	2	then	then	RB
cord-258230-s4ty52kb	23	3	,	,	,
cord-258230-s4ty52kb	23	4	there	there	EX
cord-258230-s4ty52kb	23	5	have	have	VBP
cord-258230-s4ty52kb	23	6	been	be	VBN
cord-258230-s4ty52kb	23	7	3	3	CD
cord-258230-s4ty52kb	23	8	041	041	CD
cord-258230-s4ty52kb	23	9	764	764	CD
cord-258230-s4ty52kb	23	10	confirmed	confirm	VBD
cord-258230-s4ty52kb	24	1	COVID-19	covid-19	JJ
cord-258230-s4ty52kb	24	2	patients	patient	NNS
cord-258230-s4ty52kb	24	3	in	in	IN
cord-258230-s4ty52kb	24	4	the	the	DT
cord-258230-s4ty52kb	24	5	world	world	NN
cord-258230-s4ty52kb	24	6	as	as	IN
cord-258230-s4ty52kb	24	7	of	of	IN
cord-258230-s4ty52kb	24	8	27	27	CD
cord-258230-s4ty52kb	24	9	April	April	NNP
cord-258230-s4ty52kb	24	10	2020	2020	CD
cord-258230-s4ty52kb	24	11	,	,	,
cord-258230-s4ty52kb	24	12	with	with	IN
cord-258230-s4ty52kb	24	13	a	a	DT
cord-258230-s4ty52kb	24	14	total	total	NN
cord-258230-s4ty52kb	24	15	of	of	IN
cord-258230-s4ty52kb	24	16	211	211	CD
cord-258230-s4ty52kb	24	17	167	167	CD
cord-258230-s4ty52kb	24	18	deaths	death	NNS
cord-258230-s4ty52kb	24	19	.	.	.
cord-258230-s4ty52kb	25	1	The	the	DT
cord-258230-s4ty52kb	25	2	USA	USA	NNP
cord-258230-s4ty52kb	25	3	has	have	VBZ
cord-258230-s4ty52kb	25	4	the	the	DT
cord-258230-s4ty52kb	25	5	greatest	great	JJS
cord-258230-s4ty52kb	25	6	number	number	NN
cord-258230-s4ty52kb	25	7	(	(	-LRB-
cord-258230-s4ty52kb	25	8	988	988	CD
cord-258230-s4ty52kb	25	9	189	189	CD
cord-258230-s4ty52kb	25	10	)	)	-RRB-
cord-258230-s4ty52kb	25	11	of	of	IN
cord-258230-s4ty52kb	25	12	confirmed	confirm	VBN
cord-258230-s4ty52kb	25	13	cases	case	NNS
cord-258230-s4ty52kb	25	14	,	,	,
cord-258230-s4ty52kb	25	15	with	with	IN
cord-258230-s4ty52kb	25	16	a	a	DT
cord-258230-s4ty52kb	25	17	total	total	NN
cord-258230-s4ty52kb	25	18	of	of	IN
cord-258230-s4ty52kb	25	19	56	56	CD
cord-258230-s4ty52kb	25	20	259	259	CD
cord-258230-s4ty52kb	25	21	deaths	death	NNS
cord-258230-s4ty52kb	25	22	.	.	.
cord-258230-s4ty52kb	26	1	Most	Most	JJS
cord-258230-s4ty52kb	26	2	cases	case	NNS
cord-258230-s4ty52kb	26	3	were	be	VBD
cord-258230-s4ty52kb	26	4	diagnosed	diagnose	VBN
cord-258230-s4ty52kb	26	5	in	in	IN
cord-258230-s4ty52kb	26	6	New	New	NNP
cord-258230-s4ty52kb	26	7	York	York	NNP
cord-258230-s4ty52kb	26	8	(	(	-LRB-
cord-258230-s4ty52kb	26	9	291	291	CD
cord-258230-s4ty52kb	26	10	996	996	CD
cord-258230-s4ty52kb	26	11	)	)	-RRB-
cord-258230-s4ty52kb	26	12	,	,	,
cord-258230-s4ty52kb	26	13	with	with	IN
cord-258230-s4ty52kb	26	14	a	a	DT
cord-258230-s4ty52kb	26	15	total	total	NN
cord-258230-s4ty52kb	26	16	of	of	IN
cord-258230-s4ty52kb	26	17	22	22	CD
cord-258230-s4ty52kb	26	18	668	668	CD
cord-258230-s4ty52kb	26	19	deaths	death	NNS
cord-258230-s4ty52kb	26	20	.	.	.
cord-258230-s4ty52kb	27	1	2	2	LS
cord-258230-s4ty52kb	28	1	Several	several	JJ
cord-258230-s4ty52kb	28	2	studies	study	NNS
cord-258230-s4ty52kb	28	3	,	,	,
cord-258230-s4ty52kb	28	4	including	include	VBG
cord-258230-s4ty52kb	28	5	a	a	DT
cord-258230-s4ty52kb	28	6	recent	recent	JJ
cord-258230-s4ty52kb	28	7	meta	meta	JJ
cord-258230-s4ty52kb	28	8	-	-	HYPH
cord-258230-s4ty52kb	28	9	analysis	analysis	NN
cord-258230-s4ty52kb	28	10	,	,	,
cord-258230-s4ty52kb	28	11	have	have	VBP
cord-258230-s4ty52kb	28	12	reported	report	VBN
cord-258230-s4ty52kb	28	13	that	that	IN
cord-258230-s4ty52kb	28	14	co	co	NN
cord-258230-s4ty52kb	28	15	-	-	JJ
cord-258230-s4ty52kb	28	16	existing	existing	JJ
cord-258230-s4ty52kb	28	17	conditions	condition	NNS
cord-258230-s4ty52kb	28	18	,	,	,
cord-258230-s4ty52kb	28	19	including	include	VBG
cord-258230-s4ty52kb	28	20	hypertension	hypertension	NN
cord-258230-s4ty52kb	28	21	,	,	,
cord-258230-s4ty52kb	28	22	cardiac	cardiac	JJ
cord-258230-s4ty52kb	28	23	diseases	disease	NNS
cord-258230-s4ty52kb	28	24	,	,	,
cord-258230-s4ty52kb	28	25	cerebrovascular	cerebrovascular	JJ
cord-258230-s4ty52kb	28	26	diseases	disease	NNS
cord-258230-s4ty52kb	28	27	,	,	,
cord-258230-s4ty52kb	28	28	and	and	CC
cord-258230-s4ty52kb	28	29	diabetes	diabetes	NN
cord-258230-s4ty52kb	28	30	,	,	,
cord-258230-s4ty52kb	28	31	were	be	VBD
cord-258230-s4ty52kb	28	32	common	common	JJ
cord-258230-s4ty52kb	28	33	among	among	IN
cord-258230-s4ty52kb	28	34	patients	patient	NNS
cord-258230-s4ty52kb	28	35	with	with	IN
cord-258230-s4ty52kb	28	36	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	28	37	who	who	WP
cord-258230-s4ty52kb	28	38	had	have	VBD
cord-258230-s4ty52kb	28	39	severe	severe	JJ
cord-258230-s4ty52kb	28	40	illness	illness	NN
cord-258230-s4ty52kb	28	41	,	,	,
cord-258230-s4ty52kb	28	42	were	be	VBD
cord-258230-s4ty52kb	28	43	admitted	admit	VBN
cord-258230-s4ty52kb	28	44	to	to	IN
cord-258230-s4ty52kb	28	45	the	the	DT
cord-258230-s4ty52kb	28	46	intensive	intensive	JJ
cord-258230-s4ty52kb	28	47	care	care	NN
cord-258230-s4ty52kb	28	48	unit	unit	NN
cord-258230-s4ty52kb	28	49	(	(	-LRB-
cord-258230-s4ty52kb	28	50	ICU	ICU	NNP
cord-258230-s4ty52kb	28	51	)	)	-RRB-
cord-258230-s4ty52kb	28	52	,	,	,
cord-258230-s4ty52kb	28	53	received	receive	VBD
cord-258230-s4ty52kb	28	54	mechanical	mechanical	JJ
cord-258230-s4ty52kb	28	55	ventilation	ventilation	NN
cord-258230-s4ty52kb	28	56	,	,	,
cord-258230-s4ty52kb	28	57	or	or	CC
cord-258230-s4ty52kb	28	58	died	die	VBD
cord-258230-s4ty52kb	28	59	than	than	IN
cord-258230-s4ty52kb	28	60	among	among	IN
cord-258230-s4ty52kb	28	61	patients	patient	NNS
cord-258230-s4ty52kb	28	62	who	who	WP
cord-258230-s4ty52kb	28	63	had	have	VBD
cord-258230-s4ty52kb	28	64	mild	mild	JJ
cord-258230-s4ty52kb	28	65	illness	illness	NN
cord-258230-s4ty52kb	28	66	.	.	.
cord-258230-s4ty52kb	29	1	3	3	CD
cord-258230-s4ty52kb	29	2	,	,	,
cord-258230-s4ty52kb	29	3	4	4	CD
cord-258230-s4ty52kb	29	4	Notably	notably	RB
cord-258230-s4ty52kb	29	5	,	,	,
cord-258230-s4ty52kb	29	6	of	of	IN
cord-258230-s4ty52kb	29	7	the	the	DT
cord-258230-s4ty52kb	29	8	most	most	RBS
cord-258230-s4ty52kb	29	9	frequent	frequent	JJ
cord-258230-s4ty52kb	29	10	comorbidities	comorbiditie	NNS
cord-258230-s4ty52kb	29	11	reported	report	VBN
cord-258230-s4ty52kb	29	12	in	in	IN
cord-258230-s4ty52kb	29	13	these	these	DT
cord-258230-s4ty52kb	29	14	studies	study	NNS
cord-258230-s4ty52kb	29	15	of	of	IN
cord-258230-s4ty52kb	29	16	patients	patient	NNS
cord-258230-s4ty52kb	29	17	with	with	IN
cord-258230-s4ty52kb	29	18	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	29	19	,	,	,
cord-258230-s4ty52kb	29	20	hypertension	hypertension	NN
cord-258230-s4ty52kb	29	21	in	in	IN
cord-258230-s4ty52kb	29	22	particular	particular	JJ
cord-258230-s4ty52kb	29	23	is	be	VBZ
cord-258230-s4ty52kb	29	24	often	often	RB
cord-258230-s4ty52kb	29	25	treated	treat	VBN
cord-258230-s4ty52kb	29	26	with	with	IN
cord-258230-s4ty52kb	29	27	angiotensin	angiotensin	NN
cord-258230-s4ty52kb	29	28	-	-	HYPH
cord-258230-s4ty52kb	29	29	converting	convert	VBG
cord-258230-s4ty52kb	29	30	enzyme	enzyme	NN
cord-258230-s4ty52kb	29	31	inhibitors	inhibitor	NNS
cord-258230-s4ty52kb	29	32	(	(	-LRB-
cord-258230-s4ty52kb	29	33	ACEIs	acei	NNS
cord-258230-s4ty52kb	29	34	)	)	-RRB-
cord-258230-s4ty52kb	29	35	and	and	CC
cord-258230-s4ty52kb	29	36	angiotensin	angiotensin	NN
cord-258230-s4ty52kb	29	37	receptor	receptor	NN
cord-258230-s4ty52kb	29	38	blockers	blocker	NNS
cord-258230-s4ty52kb	29	39	(	(	-LRB-
cord-258230-s4ty52kb	29	40	ARBs	arb	NNS
cord-258230-s4ty52kb	29	41	)	)	-RRB-
cord-258230-s4ty52kb	29	42	.	.	.
cord-258230-s4ty52kb	30	1	5	5	LS
cord-258230-s4ty52kb	31	1	This	this	DT
cord-258230-s4ty52kb	31	2	could	could	MD
cord-258230-s4ty52kb	31	3	theoretically	theoretically	RB
cord-258230-s4ty52kb	31	4	result	result	VB
cord-258230-s4ty52kb	31	5	in	in	IN
cord-258230-s4ty52kb	31	6	an	an	DT
cord-258230-s4ty52kb	31	7	up	up	JJ
cord-258230-s4ty52kb	31	8	-	-	HYPH
cord-258230-s4ty52kb	31	9	regulation	regulation	NN
cord-258230-s4ty52kb	31	10	of	of	IN
cord-258230-s4ty52kb	31	11	ACE2	ACE2	NNP
cord-258230-s4ty52kb	31	12	,	,	,
cord-258230-s4ty52kb	31	13	which	which	WDT
cord-258230-s4ty52kb	31	14	is	be	VBZ
cord-258230-s4ty52kb	31	15	an	an	DT
cord-258230-s4ty52kb	31	16	active	active	JJ
cord-258230-s4ty52kb	31	17	binding	binding	NN
cord-258230-s4ty52kb	31	18	target	target	NN
cord-258230-s4ty52kb	31	19	for	for	IN
cord-258230-s4ty52kb	31	20	SARS	SARS	NNP
cord-258230-s4ty52kb	31	21	-	-	HYPH
cord-258230-s4ty52kb	31	22	CoV-2	CoV-2	NNP
cord-258230-s4ty52kb	31	23	virus	virus	NN
cord-258230-s4ty52kb	31	24	,	,	,
cord-258230-s4ty52kb	31	25	6	6	CD
cord-258230-s4ty52kb	31	26	in	in	IN
cord-258230-s4ty52kb	31	27	the	the	DT
cord-258230-s4ty52kb	31	28	epithelial	epithelial	JJ
cord-258230-s4ty52kb	31	29	cells	cell	NNS
cord-258230-s4ty52kb	31	30	of	of	IN
cord-258230-s4ty52kb	31	31	the	the	DT
cord-258230-s4ty52kb	31	32	lung	lung	NN
cord-258230-s4ty52kb	31	33	,	,	,
cord-258230-s4ty52kb	31	34	intestine	intestine	NN
cord-258230-s4ty52kb	31	35	,	,	,
cord-258230-s4ty52kb	31	36	kidney	kidney	NN
cord-258230-s4ty52kb	31	37	,	,	,
cord-258230-s4ty52kb	31	38	and	and	CC
cord-258230-s4ty52kb	31	39	blood	blood	NN
cord-258230-s4ty52kb	31	40	vessels	vessel	NNS
cord-258230-s4ty52kb	31	41	.	.	.
cord-258230-s4ty52kb	32	1	Although	although	IN
cord-258230-s4ty52kb	32	2	this	this	DT
cord-258230-s4ty52kb	32	3	raised	raise	VBN
cord-258230-s4ty52kb	32	4	concerns	concern	NNS
cord-258230-s4ty52kb	32	5	regarding	regard	VBG
cord-258230-s4ty52kb	32	6	the	the	DT
cord-258230-s4ty52kb	32	7	use	use	NN
cord-258230-s4ty52kb	32	8	of	of	IN
cord-258230-s4ty52kb	32	9	these	these	DT
cord-258230-s4ty52kb	32	10	drugs	drug	NNS
cord-258230-s4ty52kb	32	11	in	in	IN
cord-258230-s4ty52kb	32	12	COVID-19	covid-19	CD
cord-258230-s4ty52kb	32	13	patients	patient	NNS
cord-258230-s4ty52kb	32	14	,	,	,
cord-258230-s4ty52kb	32	15	several	several	JJ
cord-258230-s4ty52kb	32	16	animal	animal	NN
cord-258230-s4ty52kb	32	17	studies	study	NNS
cord-258230-s4ty52kb	32	18	presented	present	VBD
cord-258230-s4ty52kb	32	19	conflicting	conflicting	JJ
cord-258230-s4ty52kb	32	20	findings	finding	NNS
cord-258230-s4ty52kb	32	21	regarding	regard	VBG
cord-258230-s4ty52kb	32	22	increased	increase	VBN
cord-258230-s4ty52kb	32	23	ACE2	ACE2	NNP
cord-258230-s4ty52kb	32	24	expression	expression	NN
cord-258230-s4ty52kb	32	25	due	due	IN
cord-258230-s4ty52kb	32	26	to	to	IN
cord-258230-s4ty52kb	32	27	ACEIs	acei	NNS
cord-258230-s4ty52kb	32	28	and	and	CC
cord-258230-s4ty52kb	32	29	ARBs	arb	NNS
cord-258230-s4ty52kb	32	30	,	,	,
cord-258230-s4ty52kb	32	31	and	and	CC
cord-258230-s4ty52kb	32	32	previous	previous	JJ
cord-258230-s4ty52kb	32	33	human	human	JJ
cord-258230-s4ty52kb	32	34	studies	study	NNS
cord-258230-s4ty52kb	32	35	suggested	suggest	VBD
cord-258230-s4ty52kb	32	36	that	that	IN
cord-258230-s4ty52kb	32	37	administration	administration	NN
cord-258230-s4ty52kb	32	38	of	of	IN
cord-258230-s4ty52kb	32	39	an	an	DT
cord-258230-s4ty52kb	32	40	ACEI	ACEI	NNP
cord-258230-s4ty52kb	32	41	/	/	SYM
cord-258230-s4ty52kb	32	42	ARB	ARB	NNP
cord-258230-s4ty52kb	32	43	does	do	VBZ
cord-258230-s4ty52kb	32	44	not	not	RB
cord-258230-s4ty52kb	32	45	increase	increase	VB
cord-258230-s4ty52kb	32	46	ACE2	ACE2	NNP
cord-258230-s4ty52kb	32	47	expression	expression	NN
cord-258230-s4ty52kb	32	48	.	.	.
cord-258230-s4ty52kb	33	1	7	7	CD
cord-258230-s4ty52kb	34	1	In	in	IN
cord-258230-s4ty52kb	34	2	light	light	NN
cord-258230-s4ty52kb	34	3	of	of	IN
cord-258230-s4ty52kb	34	4	these	these	DT
cord-258230-s4ty52kb	34	5	findings	finding	NNS
cord-258230-s4ty52kb	34	6	and	and	CC
cord-258230-s4ty52kb	34	7	a	a	DT
cord-258230-s4ty52kb	34	8	paucity	paucity	NN
cord-258230-s4ty52kb	34	9	of	of	IN
cord-258230-s4ty52kb	34	10	clinical	clinical	JJ
cord-258230-s4ty52kb	34	11	outcome	outcome	NN
cord-258230-s4ty52kb	34	12	studies	study	NNS
cord-258230-s4ty52kb	34	13	,	,	,
cord-258230-s4ty52kb	34	14	many	many	JJ
cord-258230-s4ty52kb	34	15	professional	professional	JJ
cord-258230-s4ty52kb	34	16	cardiovascular	cardiovascular	NN
cord-258230-s4ty52kb	34	17	and	and	CC
cord-258230-s4ty52kb	34	18	hypertension	hypertension	NN
cord-258230-s4ty52kb	34	19	societies	society	NNS
cord-258230-s4ty52kb	34	20	including	include	VBG
cord-258230-s4ty52kb	34	21	the	the	DT
cord-258230-s4ty52kb	34	22	European	European	NNP
cord-258230-s4ty52kb	34	23	Society	Society	NNP
cord-258230-s4ty52kb	34	24	of	of	IN
cord-258230-s4ty52kb	34	25	Cardiology	Cardiology	NNP
cord-258230-s4ty52kb	34	26	,	,	,
cord-258230-s4ty52kb	34	27	Italian	Italian	NNP
cord-258230-s4ty52kb	34	28	Society	Society	NNP
cord-258230-s4ty52kb	34	29	of	of	IN
cord-258230-s4ty52kb	34	30	Pharmacology	Pharmacology	NNP
cord-258230-s4ty52kb	34	31	,	,	,
cord-258230-s4ty52kb	34	32	International	International	NNP
cord-258230-s4ty52kb	34	33	Society	Society	NNP
cord-258230-s4ty52kb	34	34	of	of	IN
cord-258230-s4ty52kb	34	35	Hypertension	Hypertension	NNP
cord-258230-s4ty52kb	34	36	(	(	-LRB-
cord-258230-s4ty52kb	34	37	ISH	ISH	NNP
cord-258230-s4ty52kb	34	38	)	)	-RRB-
cord-258230-s4ty52kb	34	39	,	,	,
cord-258230-s4ty52kb	34	40	European	European	NNP
cord-258230-s4ty52kb	34	41	Society	Society	NNP
cord-258230-s4ty52kb	34	42	of	of	IN
cord-258230-s4ty52kb	34	43	Hypertension	Hypertension	NNP
cord-258230-s4ty52kb	34	44	,	,	,
cord-258230-s4ty52kb	34	45	Joint	Joint	NNP
cord-258230-s4ty52kb	34	46	American	American	NNP
cord-258230-s4ty52kb	34	47	Heart	Heart	NNP
cord-258230-s4ty52kb	34	48	Association	Association	NNP
cord-258230-s4ty52kb	34	49	/	/	SYM
cord-258230-s4ty52kb	34	50	American	American	NNP
cord-258230-s4ty52kb	34	51	College	College	NNP
cord-258230-s4ty52kb	34	52	of	of	IN
cord-258230-s4ty52kb	34	53	Cardiology/	Cardiology/	NNP
cord-258230-s4ty52kb	34	54	American	American	NNP
cord-258230-s4ty52kb	34	55	Heart	Heart	NNP
cord-258230-s4ty52kb	34	56	Failure	Failure	NNP
cord-258230-s4ty52kb	34	57	Association	Association	NNP
cord-258230-s4ty52kb	34	58	,	,	,
cord-258230-s4ty52kb	34	59	and	and	CC
cord-258230-s4ty52kb	34	60	others	other	NNS
cord-258230-s4ty52kb	34	61	recommended	recommend	VBD
cord-258230-s4ty52kb	34	62	the	the	DT
cord-258230-s4ty52kb	34	63	continued	continue	VBN
cord-258230-s4ty52kb	34	64	use	use	NN
cord-258230-s4ty52kb	34	65	of	of	IN
cord-258230-s4ty52kb	34	66	ACEIs	acei	NNS
cord-258230-s4ty52kb	34	67	/	/	SYM
cord-258230-s4ty52kb	34	68	ARBs	arb	NNS
cord-258230-s4ty52kb	34	69	in	in	IN
cord-258230-s4ty52kb	34	70	COVID-19	covid-19	CD
cord-258230-s4ty52kb	34	71	patients	patient	NNS
cord-258230-s4ty52kb	34	72	.	.	.
cord-258230-s4ty52kb	35	1	[	[	-LRB-
cord-258230-s4ty52kb	35	2	8	8	CD
cord-258230-s4ty52kb	35	3	]	]	-RRB-
cord-258230-s4ty52kb	35	4	[	[	-LRB-
cord-258230-s4ty52kb	35	5	9	9	CD
cord-258230-s4ty52kb	35	6	]	]	-RRB-
cord-258230-s4ty52kb	35	7	[	[	-LRB-
cord-258230-s4ty52kb	35	8	10	10	CD
cord-258230-s4ty52kb	35	9	]	]	-RRB-
cord-258230-s4ty52kb	35	10	[	[	-LRB-
cord-258230-s4ty52kb	35	11	11	11	CD
cord-258230-s4ty52kb	35	12	]	]	-RRB-
cord-258230-s4ty52kb	36	1	[	[	-LRB-
cord-258230-s4ty52kb	36	2	12	12	CD
cord-258230-s4ty52kb	36	3	]	]	-RRB-
cord-258230-s4ty52kb	37	1	However	however	RB
cord-258230-s4ty52kb	37	2	,	,	,
cord-258230-s4ty52kb	37	3	since	since	IN
cord-258230-s4ty52kb	37	4	the	the	DT
cord-258230-s4ty52kb	37	5	conception	conception	NN
cord-258230-s4ty52kb	37	6	of	of	IN
cord-258230-s4ty52kb	37	7	these	these	DT
cord-258230-s4ty52kb	37	8	recommendations	recommendation	NNS
cord-258230-s4ty52kb	37	9	,	,	,
cord-258230-s4ty52kb	37	10	several	several	JJ
cord-258230-s4ty52kb	37	11	clinical	clinical	JJ
cord-258230-s4ty52kb	37	12	studies	study	NNS
cord-258230-s4ty52kb	37	13	have	have	VBP
cord-258230-s4ty52kb	37	14	been	be	VBN
cord-258230-s4ty52kb	37	15	conducted	conduct	VBN
cord-258230-s4ty52kb	37	16	which	which	WDT
cord-258230-s4ty52kb	37	17	evaluated	evaluate	VBD
cord-258230-s4ty52kb	37	18	the	the	DT
cord-258230-s4ty52kb	37	19	association	association	NN
cord-258230-s4ty52kb	37	20	of	of	IN
cord-258230-s4ty52kb	37	21	ACEIs	acei	NNS
cord-258230-s4ty52kb	37	22	and	and	CC
cord-258230-s4ty52kb	37	23	ARBs	arb	NNS
cord-258230-s4ty52kb	37	24	with	with	IN
cord-258230-s4ty52kb	37	25	clinical	clinical	JJ
cord-258230-s4ty52kb	37	26	severity	severity	NN
cord-258230-s4ty52kb	37	27	and	and	CC
cord-258230-s4ty52kb	37	28	mortality	mortality	NN
cord-258230-s4ty52kb	37	29	outcomes	outcome	NNS
cord-258230-s4ty52kb	37	30	in	in	IN
cord-258230-s4ty52kb	37	31	COVID-19	covid-19	JJ
cord-258230-s4ty52kb	37	32	patients	patient	NNS
cord-258230-s4ty52kb	37	33	.	.	.
cord-258230-s4ty52kb	38	1	Therefore	therefore	RB
cord-258230-s4ty52kb	38	2	,	,	,
cord-258230-s4ty52kb	38	3	the	the	DT
cord-258230-s4ty52kb	38	4	medical	medical	JJ
cord-258230-s4ty52kb	38	5	literature	literature	NN
cord-258230-s4ty52kb	38	6	was	be	VBD
cord-258230-s4ty52kb	38	7	systematically	systematically	RB
cord-258230-s4ty52kb	38	8	reviewed	review	VBN
cord-258230-s4ty52kb	38	9	,	,	,
cord-258230-s4ty52kb	38	10	and	and	CC
cord-258230-s4ty52kb	38	11	a	a	DT
cord-258230-s4ty52kb	38	12	meta	meta	JJ
cord-258230-s4ty52kb	38	13	-	-	HYPH
cord-258230-s4ty52kb	38	14	analysis	analysis	NN
cord-258230-s4ty52kb	38	15	was	be	VBD
cord-258230-s4ty52kb	38	16	performed	perform	VBN
cord-258230-s4ty52kb	38	17	of	of	IN
cord-258230-s4ty52kb	38	18	the	the	DT
cord-258230-s4ty52kb	38	19	current	current	JJ
cord-258230-s4ty52kb	38	20	clinical	clinical	JJ
cord-258230-s4ty52kb	38	21	studies	study	NNS
cord-258230-s4ty52kb	38	22	evaluating	evaluate	VBG
cord-258230-s4ty52kb	38	23	the	the	DT
cord-258230-s4ty52kb	38	24	safety	safety	NN
cord-258230-s4ty52kb	38	25	and	and	CC
cord-258230-s4ty52kb	38	26	efficacy	efficacy	NN
cord-258230-s4ty52kb	38	27	of	of	IN
cord-258230-s4ty52kb	38	28	ACEs	ace	NNS
cord-258230-s4ty52kb	38	29	and	and	CC
cord-258230-s4ty52kb	38	30	ARBs	arb	NNS
cord-258230-s4ty52kb	38	31	in	in	IN
cord-258230-s4ty52kb	38	32	COVID-19	covid-19	CD
cord-258230-s4ty52kb	38	33	patients	patient	NNS
cord-258230-s4ty52kb	38	34	.	.	.
cord-258230-s4ty52kb	39	1	A	a	DT
cord-258230-s4ty52kb	39	2	literature	literature	NN
cord-258230-s4ty52kb	39	3	search	search	NN
cord-258230-s4ty52kb	39	4	was	be	VBD
cord-258230-s4ty52kb	39	5	conducted	conduct	VBN
cord-258230-s4ty52kb	39	6	on	on	IN
cord-258230-s4ty52kb	39	7	the	the	DT
cord-258230-s4ty52kb	39	8	PubMed	PubMed	NNP
cord-258230-s4ty52kb	39	9	/	/	SYM
cord-258230-s4ty52kb	39	10	MEDLINE	MEDLINE	NNP
cord-258230-s4ty52kb	39	11	database	database	NN
cord-258230-s4ty52kb	39	12	using	use	VBG
cord-258230-s4ty52kb	39	13	keywords	keyword	NNS
cord-258230-s4ty52kb	39	14	,	,	,
cord-258230-s4ty52kb	39	15	i.e.	i.e.	FW
cord-258230-s4ty52kb	39	16	'	'	''
cord-258230-s4ty52kb	39	17	ACE	ace	NN
cord-258230-s4ty52kb	39	18	inhibitors	inhibitor	NNS
cord-258230-s4ty52kb	39	19	AND	and	CC
cord-258230-s4ty52kb	39	20	COVID	COVID	NNP
cord-258230-s4ty52kb	39	21	'	'	''
cord-258230-s4ty52kb	39	22	and	and	CC
cord-258230-s4ty52kb	39	23	'	'	``
cord-258230-s4ty52kb	39	24	ARB	ARB	NNP
cord-258230-s4ty52kb	39	25	AND	and	CC
cord-258230-s4ty52kb	39	26	COVID	COVID	NNP
cord-258230-s4ty52kb	39	27	'	'	''
cord-258230-s4ty52kb	39	28	.	.	.
cord-258230-s4ty52kb	40	1	We	-PRON-	PRP
cord-258230-s4ty52kb	40	2	applied	apply	VBD
cord-258230-s4ty52kb	40	3	search	search	NN
cord-258230-s4ty52kb	40	4	filters	filter	NNS
cord-258230-s4ty52kb	40	5	to	to	TO
cord-258230-s4ty52kb	40	6	include	include	VB
cord-258230-s4ty52kb	40	7	humans	human	NNS
cord-258230-s4ty52kb	40	8	and	and	CC
cord-258230-s4ty52kb	40	9	English	english	JJ
cord-258230-s4ty52kb	40	10	language	language	NN
cord-258230-s4ty52kb	40	11	studies	study	NNS
cord-258230-s4ty52kb	40	12	published	publish	VBN
cord-258230-s4ty52kb	40	13	up	up	RP
cord-258230-s4ty52kb	40	14	to	to	IN
cord-258230-s4ty52kb	40	15	1	1	CD
cord-258230-s4ty52kb	40	16	May	May	NNP
cord-258230-s4ty52kb	40	17	2020	2020	CD
cord-258230-s4ty52kb	40	18	.	.	.
cord-258230-s4ty52kb	41	1	Additional	additional	JJ
cord-258230-s4ty52kb	41	2	papers	paper	NNS
cord-258230-s4ty52kb	41	3	of	of	IN
cord-258230-s4ty52kb	41	4	possible	possible	JJ
cord-258230-s4ty52kb	41	5	interest	interest	NN
cord-258230-s4ty52kb	41	6	were	be	VBD
cord-258230-s4ty52kb	41	7	identified	identify	VBN
cord-258230-s4ty52kb	41	8	by	by	IN
cord-258230-s4ty52kb	41	9	examining	examine	VBG
cord-258230-s4ty52kb	41	10	references	reference	NNS
cord-258230-s4ty52kb	41	11	of	of	IN
cord-258230-s4ty52kb	41	12	pertinent	pertinent	JJ
cord-258230-s4ty52kb	41	13	review	review	NN
cord-258230-s4ty52kb	41	14	articles	article	NNS
cord-258230-s4ty52kb	41	15	and	and	CC
cord-258230-s4ty52kb	41	16	searching	search	VBG
cord-258230-s4ty52kb	41	17	Google	Google	NNP
cord-258230-s4ty52kb	41	18	Scholar	scholar	NN
cord-258230-s4ty52kb	41	19	and	and	CC
cord-258230-s4ty52kb	41	20	preprint	preprint	NN
cord-258230-s4ty52kb	41	21	servers	server	NNS
cord-258230-s4ty52kb	41	22	such	such	JJ
cord-258230-s4ty52kb	41	23	as	as	IN
cord-258230-s4ty52kb	41	24	MedRxiv	MedRxiv	NNP
cord-258230-s4ty52kb	41	25	and	and	CC
cord-258230-s4ty52kb	41	26	BioRxiv	BioRxiv	NNP
cord-258230-s4ty52kb	41	27	.	.	.
cord-258230-s4ty52kb	42	1	We	-PRON-	PRP
cord-258230-s4ty52kb	42	2	included	include	VBD
cord-258230-s4ty52kb	42	3	studies	study	NNS
cord-258230-s4ty52kb	42	4	which	which	WDT
cord-258230-s4ty52kb	42	5	evaluated	evaluate	VBD
cord-258230-s4ty52kb	42	6	clinical	clinical	JJ
cord-258230-s4ty52kb	42	7	severity	severity	NN
cord-258230-s4ty52kb	42	8	and	and	CC
cord-258230-s4ty52kb	42	9	mortality	mortality	NN
cord-258230-s4ty52kb	42	10	outcomes	outcome	NNS
cord-258230-s4ty52kb	42	11	for	for	IN
cord-258230-s4ty52kb	42	12	patients	patient	NNS
cord-258230-s4ty52kb	42	13	with	with	IN
cord-258230-s4ty52kb	42	14	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	42	15	on	on	IN
cord-258230-s4ty52kb	42	16	an	an	DT
cord-258230-s4ty52kb	42	17	ACEI	ACEI	NNP
cord-258230-s4ty52kb	42	18	,	,	,
cord-258230-s4ty52kb	42	19	an	an	DT
cord-258230-s4ty52kb	42	20	ARB	arb	NN
cord-258230-s4ty52kb	42	21	,	,	,
cord-258230-s4ty52kb	42	22	or	or	CC
cord-258230-s4ty52kb	42	23	both	both	DT
cord-258230-s4ty52kb	42	24	.	.	.
cord-258230-s4ty52kb	43	1	We	-PRON-	PRP
cord-258230-s4ty52kb	43	2	excluded	exclude	VBD
cord-258230-s4ty52kb	43	3	those	those	DT
cord-258230-s4ty52kb	43	4	studies	study	NNS
cord-258230-s4ty52kb	43	5	which	which	WDT
cord-258230-s4ty52kb	43	6	were	be	VBD
cord-258230-s4ty52kb	43	7	in	in	IN
cord-258230-s4ty52kb	43	8	vitro	vitro	FW
cord-258230-s4ty52kb	43	9	or	or	CC
cord-258230-s4ty52kb	43	10	conducted	conduct	VBN
cord-258230-s4ty52kb	43	11	in	in	IN
cord-258230-s4ty52kb	43	12	animal	animal	NN
cord-258230-s4ty52kb	43	13	models	model	NNS
cord-258230-s4ty52kb	43	14	,	,	,
cord-258230-s4ty52kb	43	15	as	as	RB
cord-258230-s4ty52kb	43	16	well	well	RB
cord-258230-s4ty52kb	43	17	as	as	IN
cord-258230-s4ty52kb	43	18	those	those	DT
cord-258230-s4ty52kb	43	19	human	human	JJ
cord-258230-s4ty52kb	43	20	studies	study	NNS
cord-258230-s4ty52kb	43	21	which	which	WDT
cord-258230-s4ty52kb	43	22	evaluated	evaluate	VBD
cord-258230-s4ty52kb	43	23	only	only	RB
cord-258230-s4ty52kb	43	24	ACE	ace	NN
cord-258230-s4ty52kb	43	25	expression	expression	NN
cord-258230-s4ty52kb	43	26	levels	level	NNS
cord-258230-s4ty52kb	43	27	(	(	-LRB-
cord-258230-s4ty52kb	43	28	Figure	figure	NN
cord-258230-s4ty52kb	43	29	1	1	CD
cord-258230-s4ty52kb	43	30	)	)	-RRB-
cord-258230-s4ty52kb	43	31	.	.	.
cord-258230-s4ty52kb	44	1	Information	information	NN
cord-258230-s4ty52kb	44	2	on	on	IN
cord-258230-s4ty52kb	44	3	the	the	DT
cord-258230-s4ty52kb	44	4	demographics	demographic	NNS
cord-258230-s4ty52kb	44	5	,	,	,
cord-258230-s4ty52kb	44	6	comorbidities	comorbiditie	NNS
cord-258230-s4ty52kb	44	7	,	,	,
cord-258230-s4ty52kb	44	8	and	and	CC
cord-258230-s4ty52kb	44	9	pharmacotherapy	pharmacotherapy	NN
cord-258230-s4ty52kb	44	10	with	with	IN
cord-258230-s4ty52kb	44	11	ACEIs	acei	NNS
cord-258230-s4ty52kb	44	12	,	,	,
cord-258230-s4ty52kb	44	13	ARBs	arb	NNS
cord-258230-s4ty52kb	44	14	,	,	,
cord-258230-s4ty52kb	44	15	and	and	CC
cord-258230-s4ty52kb	44	16	other	other	JJ
cord-258230-s4ty52kb	44	17	drugs	drug	NNS
cord-258230-s4ty52kb	44	18	,	,	,
cord-258230-s4ty52kb	44	19	clinical	clinical	JJ
cord-258230-s4ty52kb	44	20	severity	severity	NN
cord-258230-s4ty52kb	44	21	outcomes	outcome	NNS
cord-258230-s4ty52kb	44	22	,	,	,
cord-258230-s4ty52kb	44	23	and	and	CC
cord-258230-s4ty52kb	44	24	mortality	mortality	NN
cord-258230-s4ty52kb	44	25	was	be	VBD
cord-258230-s4ty52kb	44	26	extracted	extract	VBN
cord-258230-s4ty52kb	44	27	.	.	.
cord-258230-s4ty52kb	45	1	The	the	DT
cord-258230-s4ty52kb	45	2	meta	meta	JJ
cord-258230-s4ty52kb	45	3	-	-	HYPH
cord-258230-s4ty52kb	45	4	analysis	analysis	NN
cord-258230-s4ty52kb	45	5	for	for	IN
cord-258230-s4ty52kb	45	6	severity	severity	NN
cord-258230-s4ty52kb	45	7	and	and	CC
cord-258230-s4ty52kb	45	8	mortality	mortality	NN
cord-258230-s4ty52kb	45	9	was	be	VBD
cord-258230-s4ty52kb	45	10	conducted	conduct	VBN
cord-258230-s4ty52kb	45	11	for	for	IN
cord-258230-s4ty52kb	45	12	four	four	CD
cord-258230-s4ty52kb	45	13	and	and	CC
cord-258230-s4ty52kb	45	14	six	six	CD
cord-258230-s4ty52kb	45	15	peer	peer	NN
cord-258230-s4ty52kb	45	16	-	-	HYPH
cord-258230-s4ty52kb	45	17	reviewed	review	VBN
cord-258230-s4ty52kb	45	18	studies	study	NNS
cord-258230-s4ty52kb	45	19	,	,	,
cord-258230-s4ty52kb	45	20	respectively	respectively	RB
cord-258230-s4ty52kb	45	21	,	,	,
cord-258230-s4ty52kb	45	22	using	use	VBG
cord-258230-s4ty52kb	45	23	the	the	DT
cord-258230-s4ty52kb	45	24	comprehensive	comprehensive	JJ
cord-258230-s4ty52kb	45	25	metaanalysis	metaanalysis	NN
cord-258230-s4ty52kb	45	26	(	(	-LRB-
cord-258230-s4ty52kb	45	27	CMA	CMA	NNP
cord-258230-s4ty52kb	45	28	)	)	-RRB-
cord-258230-s4ty52kb	45	29	software	software	NN
cord-258230-s4ty52kb	45	30	version	version	NN
cord-258230-s4ty52kb	45	31	3	3	CD
cord-258230-s4ty52kb	45	32	(	(	-LRB-
cord-258230-s4ty52kb	45	33	Biostat	Biostat	NNP
cord-258230-s4ty52kb	45	34	Inc.	Inc.	NNP
cord-258230-s4ty52kb	45	35	,	,	,
cord-258230-s4ty52kb	45	36	Englewood	Englewood	NNP
cord-258230-s4ty52kb	45	37	,	,	,
cord-258230-s4ty52kb	45	38	NJ	NJ	NNP
cord-258230-s4ty52kb	45	39	,	,	,
cord-258230-s4ty52kb	45	40	USA	USA	NNP
cord-258230-s4ty52kb	45	41	)	)	-RRB-
cord-258230-s4ty52kb	45	42	.	.	.
cord-258230-s4ty52kb	46	1	The	the	DT
cord-258230-s4ty52kb	46	2	studies	study	NNS
cord-258230-s4ty52kb	46	3	were	be	VBD
cord-258230-s4ty52kb	46	4	assessed	assess	VBN
cord-258230-s4ty52kb	46	5	for	for	IN
cord-258230-s4ty52kb	46	6	methodological	methodological	JJ
cord-258230-s4ty52kb	46	7	quality	quality	NN
cord-258230-s4ty52kb	46	8	based	base	VBN
cord-258230-s4ty52kb	46	9	on	on	IN
cord-258230-s4ty52kb	46	10	the	the	DT
cord-258230-s4ty52kb	46	11	Newcastle	Newcastle	NNP
cord-258230-s4ty52kb	46	12	-	-	HYPH
cord-258230-s4ty52kb	46	13	Ottawa	Ottawa	NNP
cord-258230-s4ty52kb	46	14	Scale	Scale	NNP
cord-258230-s4ty52kb	46	15	(	(	-LRB-
cord-258230-s4ty52kb	46	16	NOS	NOS	NNP
cord-258230-s4ty52kb	46	17	)	)	-RRB-
cord-258230-s4ty52kb	46	18	.	.	.
cord-258230-s4ty52kb	47	1	13	13	CD
cord-258230-s4ty52kb	48	1	The	the	DT
cord-258230-s4ty52kb	48	2	NOS	NOS	NNP
cord-258230-s4ty52kb	48	3	has	have	VBZ
cord-258230-s4ty52kb	48	4	eight	eight	CD
cord-258230-s4ty52kb	48	5	criteria	criterion	NNS
cord-258230-s4ty52kb	48	6	and	and	CC
cord-258230-s4ty52kb	48	7	generates	generate	VBZ
cord-258230-s4ty52kb	48	8	scores	score	NNS
cord-258230-s4ty52kb	48	9	ranging	range	VBG
cord-258230-s4ty52kb	48	10	from	from	IN
cord-258230-s4ty52kb	48	11	0	0	CD
cord-258230-s4ty52kb	48	12	(	(	-LRB-
cord-258230-s4ty52kb	48	13	high	high	JJ
cord-258230-s4ty52kb	48	14	risk	risk	NN
cord-258230-s4ty52kb	48	15	of	of	IN
cord-258230-s4ty52kb	48	16	bias	bias	NN
cord-258230-s4ty52kb	48	17	)	)	-RRB-
cord-258230-s4ty52kb	48	18	to	to	IN
cord-258230-s4ty52kb	48	19	9	9	CD
cord-258230-s4ty52kb	48	20	(	(	-LRB-
cord-258230-s4ty52kb	48	21	low	low	JJ
cord-258230-s4ty52kb	48	22	risk	risk	NN
cord-258230-s4ty52kb	48	23	of	of	IN
cord-258230-s4ty52kb	48	24	bias	bias	NN
cord-258230-s4ty52kb	48	25	)	)	-RRB-
cord-258230-s4ty52kb	48	26	.	.	.
cord-258230-s4ty52kb	49	1	Studies	study	NNS
cord-258230-s4ty52kb	49	2	with	with	IN
cord-258230-s4ty52kb	49	3	NOS	NOS	NNP
cord-258230-s4ty52kb	49	4	scores	score	NNS
cord-258230-s4ty52kb	49	5	of	of	IN
cord-258230-s4ty52kb	49	6	>	>	SYM
cord-258230-s4ty52kb	49	7	7	7	CD
cord-258230-s4ty52kb	49	8	were	be	VBD
cord-258230-s4ty52kb	49	9	regarded	regard	VBN
cord-258230-s4ty52kb	49	10	as	as	IN
cord-258230-s4ty52kb	49	11	high	high	JJ
cord-258230-s4ty52kb	49	12	quality	quality	NN
cord-258230-s4ty52kb	49	13	.	.	.
cord-258230-s4ty52kb	50	1	Heterogeneity	heterogeneity	NN
cord-258230-s4ty52kb	50	2	was	be	VBD
cord-258230-s4ty52kb	50	3	assessed	assess	VBN
cord-258230-s4ty52kb	50	4	using	use	VBG
cord-258230-s4ty52kb	50	5	the	the	DT
cord-258230-s4ty52kb	50	6	Higgin	Higgin	NNP
cord-258230-s4ty52kb	50	7	's	's	POS
cord-258230-s4ty52kb	50	8	I	i	NN
cord-258230-s4ty52kb	50	9	2	2	CD
cord-258230-s4ty52kb	50	10	test	test	NN
cord-258230-s4ty52kb	50	11	,	,	,
cord-258230-s4ty52kb	50	12	and	and	CC
cord-258230-s4ty52kb	50	13	the	the	DT
cord-258230-s4ty52kb	50	14	choice	choice	NN
cord-258230-s4ty52kb	50	15	of	of	IN
cord-258230-s4ty52kb	50	16	fixed	fixed	JJ
cord-258230-s4ty52kb	50	17	or	or	CC
cord-258230-s4ty52kb	50	18	random	random	JJ
cord-258230-s4ty52kb	50	19	effects	effect	NNS
cord-258230-s4ty52kb	50	20	model	model	NN
cord-258230-s4ty52kb	50	21	was	be	VBD
cord-258230-s4ty52kb	50	22	made	make	VBN
cord-258230-s4ty52kb	50	23	based	base	VBN
cord-258230-s4ty52kb	50	24	on	on	IN
cord-258230-s4ty52kb	50	25	the	the	DT
cord-258230-s4ty52kb	50	26	calculated	calculate	VBN
cord-258230-s4ty52kb	50	27	heterogeneity	heterogeneity	NN
cord-258230-s4ty52kb	50	28	.	.	.
cord-258230-s4ty52kb	51	1	The	the	DT
cord-258230-s4ty52kb	51	2	publication	publication	NN
cord-258230-s4ty52kb	51	3	bias	bias	NN
cord-258230-s4ty52kb	51	4	was	be	VBD
cord-258230-s4ty52kb	51	5	reported	report	VBN
cord-258230-s4ty52kb	51	6	by	by	IN
cord-258230-s4ty52kb	51	7	using	use	VBG
cord-258230-s4ty52kb	51	8	funnel	funnel	NN
cord-258230-s4ty52kb	51	9	plots	plot	NNS
cord-258230-s4ty52kb	51	10	.	.	.
cord-258230-s4ty52kb	52	1	We	-PRON-	PRP
cord-258230-s4ty52kb	52	2	reported	report	VBD
cord-258230-s4ty52kb	52	3	the	the	DT
cord-258230-s4ty52kb	52	4	findings	finding	NNS
cord-258230-s4ty52kb	52	5	based	base	VBN
cord-258230-s4ty52kb	52	6	on	on	IN
cord-258230-s4ty52kb	52	7	both	both	CC
cord-258230-s4ty52kb	52	8	a	a	DT
cord-258230-s4ty52kb	52	9	fixed	fixed	JJ
cord-258230-s4ty52kb	52	10	and	and	CC
cord-258230-s4ty52kb	52	11	random	random	JJ
cord-258230-s4ty52kb	52	12	effects	effect	NNS
cord-258230-s4ty52kb	52	13	model	model	NN
cord-258230-s4ty52kb	52	14	derived	derive	VBN
cord-258230-s4ty52kb	52	15	from	from	IN
cord-258230-s4ty52kb	52	16	the	the	DT
cord-258230-s4ty52kb	52	17	heterogeneity	heterogeneity	NN
cord-258230-s4ty52kb	52	18	of	of	IN
cord-258230-s4ty52kb	52	19	the	the	DT
cord-258230-s4ty52kb	52	20	studies	study	NNS
cord-258230-s4ty52kb	52	21	.	.	.
cord-258230-s4ty52kb	53	1	A	a	DT
cord-258230-s4ty52kb	53	2	total	total	NN
cord-258230-s4ty52kb	53	3	of	of	IN
cord-258230-s4ty52kb	53	4	276	276	CD
cord-258230-s4ty52kb	53	5	articles	article	NNS
cord-258230-s4ty52kb	53	6	were	be	VBD
cord-258230-s4ty52kb	53	7	found	find	VBN
cord-258230-s4ty52kb	53	8	in	in	IN
cord-258230-s4ty52kb	53	9	the	the	DT
cord-258230-s4ty52kb	53	10	search	search	NN
cord-258230-s4ty52kb	53	11	.	.	.
cord-258230-s4ty52kb	54	1	Based	base	VBN
cord-258230-s4ty52kb	54	2	on	on	IN
cord-258230-s4ty52kb	54	3	the	the	DT
cord-258230-s4ty52kb	54	4	screening	screening	NN
cord-258230-s4ty52kb	54	5	of	of	IN
cord-258230-s4ty52kb	54	6	titles	title	NNS
cord-258230-s4ty52kb	54	7	of	of	IN
cord-258230-s4ty52kb	54	8	the	the	DT
cord-258230-s4ty52kb	54	9	articles	article	NNS
cord-258230-s4ty52kb	54	10	,	,	,
cord-258230-s4ty52kb	54	11	178	178	CD
cord-258230-s4ty52kb	54	12	were	be	VBD
cord-258230-s4ty52kb	54	13	excluded	exclude	VBN
cord-258230-s4ty52kb	54	14	as	as	IN
cord-258230-s4ty52kb	54	15	they	-PRON-	PRP
cord-258230-s4ty52kb	54	16	did	do	VBD
cord-258230-s4ty52kb	54	17	not	not	RB
cord-258230-s4ty52kb	54	18	meet	meet	VB
cord-258230-s4ty52kb	54	19	the	the	DT
cord-258230-s4ty52kb	54	20	inclusion	inclusion	NN
cord-258230-s4ty52kb	54	21	criteria	criterion	NNS
cord-258230-s4ty52kb	54	22	.	.	.
cord-258230-s4ty52kb	55	1	Further	further	RB
cord-258230-s4ty52kb	55	2	,	,	,
cord-258230-s4ty52kb	55	3	abstracts	abstract	NNS
cord-258230-s4ty52kb	55	4	of	of	IN
cord-258230-s4ty52kb	55	5	98	98	CD
cord-258230-s4ty52kb	55	6	articles	article	NNS
cord-258230-s4ty52kb	55	7	were	be	VBD
cord-258230-s4ty52kb	55	8	read	read	VBN
cord-258230-s4ty52kb	55	9	and	and	CC
cord-258230-s4ty52kb	55	10	,	,	,
cord-258230-s4ty52kb	55	11	subsequently	subsequently	RB
cord-258230-s4ty52kb	55	12	,	,	,
cord-258230-s4ty52kb	55	13	the	the	DT
cord-258230-s4ty52kb	55	14	full	full	JJ
cord-258230-s4ty52kb	55	15	text	text	NN
cord-258230-s4ty52kb	55	16	of	of	IN
cord-258230-s4ty52kb	55	17	41	41	CD
cord-258230-s4ty52kb	55	18	articles	article	NNS
cord-258230-s4ty52kb	55	19	were	be	VBD
cord-258230-s4ty52kb	55	20	reviewed	review	VBN
cord-258230-s4ty52kb	55	21	.	.	.
cord-258230-s4ty52kb	56	1	Of	of	IN
cord-258230-s4ty52kb	56	2	these	these	DT
cord-258230-s4ty52kb	56	3	,	,	,
cord-258230-s4ty52kb	56	4	16	16	CD
cord-258230-s4ty52kb	56	5	articles	article	NNS
cord-258230-s4ty52kb	56	6	were	be	VBD
cord-258230-s4ty52kb	56	7	shortlisted	shortlist	VBN
cord-258230-s4ty52kb	56	8	which	which	WDT
cord-258230-s4ty52kb	56	9	compared	compare	VBD
cord-258230-s4ty52kb	56	10	the	the	DT
cord-258230-s4ty52kb	56	11	clinical	clinical	JJ
cord-258230-s4ty52kb	56	12	and/or	and/or	CC
cord-258230-s4ty52kb	56	13	mortality	mortality	NN
cord-258230-s4ty52kb	56	14	outcomes	outcome	NNS
cord-258230-s4ty52kb	56	15	of	of	IN
cord-258230-s4ty52kb	56	16	COVID-19	covid-19	JJ
cord-258230-s4ty52kb	56	17	patients	patient	NNS
cord-258230-s4ty52kb	56	18	on	on	IN
cord-258230-s4ty52kb	56	19	an	an	DT
cord-258230-s4ty52kb	56	20	ACEI	ACEI	NNP
cord-258230-s4ty52kb	56	21	or	or	CC
cord-258230-s4ty52kb	56	22	ARB	ARB	NNP
cord-258230-s4ty52kb	56	23	with	with	IN
cord-258230-s4ty52kb	56	24	nonusers	nonuser	NNS
cord-258230-s4ty52kb	56	25	.	.	.
cord-258230-s4ty52kb	57	1	[	[	-LRB-
cord-258230-s4ty52kb	57	2	14	14	CD
cord-258230-s4ty52kb	57	3	]	]	-RRB-
cord-258230-s4ty52kb	57	4	[	[	-LRB-
cord-258230-s4ty52kb	57	5	15	15	CD
cord-258230-s4ty52kb	57	6	]	]	-RRB-
cord-258230-s4ty52kb	57	7	[	[	-LRB-
cord-258230-s4ty52kb	57	8	16	16	CD
cord-258230-s4ty52kb	57	9	]	]	-RRB-
cord-258230-s4ty52kb	57	10	[	[	-LRB-
cord-258230-s4ty52kb	57	11	17	17	CD
cord-258230-s4ty52kb	57	12	]	]	-RRB-
cord-258230-s4ty52kb	57	13	[	[	-LRB-
cord-258230-s4ty52kb	57	14	18	18	CD
cord-258230-s4ty52kb	57	15	]	]	-RRB-
cord-258230-s4ty52kb	57	16	[	[	-LRB-
cord-258230-s4ty52kb	57	17	19	19	CD
cord-258230-s4ty52kb	57	18	]	]	-RRB-
cord-258230-s4ty52kb	58	1	[	[	-LRB-
cord-258230-s4ty52kb	58	2	20	20	CD
cord-258230-s4ty52kb	58	3	]	]	-RRB-
cord-258230-s4ty52kb	58	4	[	[	-LRB-
cord-258230-s4ty52kb	58	5	21	21	CD
cord-258230-s4ty52kb	58	6	]	]	-RRB-
cord-258230-s4ty52kb	59	1	[	[	-LRB-
cord-258230-s4ty52kb	59	2	22	22	CD
cord-258230-s4ty52kb	59	3	]	]	-RRB-
cord-258230-s4ty52kb	59	4	[	[	-LRB-
cord-258230-s4ty52kb	59	5	23	23	CD
cord-258230-s4ty52kb	59	6	]	]	-RRB-
cord-258230-s4ty52kb	60	1	[	[	-LRB-
cord-258230-s4ty52kb	60	2	24	24	CD
cord-258230-s4ty52kb	60	3	]	]	-RRB-
cord-258230-s4ty52kb	60	4	[	[	-LRB-
cord-258230-s4ty52kb	60	5	25	25	CD
cord-258230-s4ty52kb	60	6	]	]	-RRB-
cord-258230-s4ty52kb	60	7	[	[	-LRB-
cord-258230-s4ty52kb	60	8	26	26	CD
cord-258230-s4ty52kb	60	9	]	]	-RRB-
cord-258230-s4ty52kb	60	10	[	[	-LRB-
cord-258230-s4ty52kb	60	11	27	27	CD
cord-258230-s4ty52kb	60	12	]	]	-RRB-
cord-258230-s4ty52kb	61	1	[	[	-LRB-
cord-258230-s4ty52kb	61	2	28	28	CD
cord-258230-s4ty52kb	61	3	]	]	-RRB-
cord-258230-s4ty52kb	62	1	[	[	-LRB-
cord-258230-s4ty52kb	62	2	29	29	CD
cord-258230-s4ty52kb	62	3	]	]	-RRB-
cord-258230-s4ty52kb	63	1	Finally	finally	RB
cord-258230-s4ty52kb	63	2	,	,	,
cord-258230-s4ty52kb	63	3	these	these	DT
cord-258230-s4ty52kb	63	4	16	16	CD
cord-258230-s4ty52kb	63	5	studies	study	NNS
cord-258230-s4ty52kb	63	6	were	be	VBD
cord-258230-s4ty52kb	63	7	included	include	VBN
cord-258230-s4ty52kb	63	8	for	for	IN
cord-258230-s4ty52kb	63	9	review	review	NN
cord-258230-s4ty52kb	63	10	and	and	CC
cord-258230-s4ty52kb	63	11	,	,	,
cord-258230-s4ty52kb	63	12	out	out	IN
cord-258230-s4ty52kb	63	13	of	of	IN
cord-258230-s4ty52kb	63	14	these	these	DT
cord-258230-s4ty52kb	63	15	,	,	,
cord-258230-s4ty52kb	63	16	six	six	CD
cord-258230-s4ty52kb	63	17	and	and	CC
cord-258230-s4ty52kb	63	18	four	four	CD
cord-258230-s4ty52kb	63	19	studies	study	NNS
cord-258230-s4ty52kb	63	20	were	be	VBD
cord-258230-s4ty52kb	63	21	included	include	VBN
cord-258230-s4ty52kb	63	22	in	in	IN
cord-258230-s4ty52kb	63	23	the	the	DT
cord-258230-s4ty52kb	63	24	meta	meta	NNP
cord-258230-s4ty52kb	63	25	-	-	HYPH
cord-258230-s4ty52kb	63	26	analysis	analysis	NN
cord-258230-s4ty52kb	63	27	of	of	IN
cord-258230-s4ty52kb	63	28	mortality	mortality	NN
cord-258230-s4ty52kb	63	29	and	and	CC
cord-258230-s4ty52kb	63	30	severity	severity	NN
cord-258230-s4ty52kb	63	31	outcomes	outcome	NNS
cord-258230-s4ty52kb	63	32	in	in	IN
cord-258230-s4ty52kb	63	33	COVID-19	covid-19	JJ
cord-258230-s4ty52kb	63	34	patients	patient	NNS
cord-258230-s4ty52kb	63	35	on	on	IN
cord-258230-s4ty52kb	63	36	an	an	DT
cord-258230-s4ty52kb	63	37	ACEI/	ACEI/	NNP
cord-258230-s4ty52kb	63	38	ARB	ARB	NNP
cord-258230-s4ty52kb	63	39	,	,	,
cord-258230-s4ty52kb	63	40	respectively	respectively	RB
cord-258230-s4ty52kb	63	41	(	(	-LRB-
cord-258230-s4ty52kb	63	42	Table	table	NN
cord-258230-s4ty52kb	63	43	1	1	CD
cord-258230-s4ty52kb	63	44	)	)	-RRB-
cord-258230-s4ty52kb	63	45	.	.	.
cord-258230-s4ty52kb	64	1	14	14	CD
cord-258230-s4ty52kb	64	2	,	,	,
cord-258230-s4ty52kb	64	3	20	20	CD
cord-258230-s4ty52kb	64	4	,	,	,
cord-258230-s4ty52kb	64	5	[	[	-LRB-
cord-258230-s4ty52kb	64	6	22	22	CD
cord-258230-s4ty52kb	64	7	]	]	-RRB-
cord-258230-s4ty52kb	64	8	[	[	-LRB-
cord-258230-s4ty52kb	64	9	23	23	CD
cord-258230-s4ty52kb	64	10	]	]	-RRB-
cord-258230-s4ty52kb	64	11	[	[	-LRB-
cord-258230-s4ty52kb	64	12	24	24	CD
cord-258230-s4ty52kb	64	13	]	]	-RRB-
cord-258230-s4ty52kb	64	14	27	27	CD
cord-258230-s4ty52kb	64	15	(	(	-LRB-
cord-258230-s4ty52kb	64	16	Table	table	NN
cord-258230-s4ty52kb	64	17	2	2	CD
cord-258230-s4ty52kb	64	18	)	)	-RRB-
cord-258230-s4ty52kb	64	19	Table	table	NN
cord-258230-s4ty52kb	64	20	2	2	CD
cord-258230-s4ty52kb	64	21	)	)	-RRB-
cord-258230-s4ty52kb	64	22	.	.	.
cord-258230-s4ty52kb	65	1	In	in	IN
cord-258230-s4ty52kb	65	2	a	a	DT
cord-258230-s4ty52kb	65	3	pooled	pool	VBN
cord-258230-s4ty52kb	65	4	analysis	analysis	NN
cord-258230-s4ty52kb	65	5	of	of	IN
cord-258230-s4ty52kb	65	6	four	four	CD
cord-258230-s4ty52kb	65	7	peer	peer	NN
cord-258230-s4ty52kb	65	8	-	-	HYPH
cord-258230-s4ty52kb	65	9	reviewed	review	VBN
cord-258230-s4ty52kb	65	10	studies	study	NNS
cord-258230-s4ty52kb	65	11	,	,	,
cord-258230-s4ty52kb	65	12	there	there	EX
cord-258230-s4ty52kb	65	13	was	be	VBD
cord-258230-s4ty52kb	65	14	a	a	DT
cord-258230-s4ty52kb	65	15	statistically	statistically	RB
cord-258230-s4ty52kb	65	16	non	non	JJ
cord-258230-s4ty52kb	65	17	-	-	JJ
cord-258230-s4ty52kb	65	18	significant	significant	JJ
cord-258230-s4ty52kb	65	19	association	association	NN
cord-258230-s4ty52kb	65	20	of	of	IN
cord-258230-s4ty52kb	65	21	an	an	DT
cord-258230-s4ty52kb	65	22	ACEI	ACEI	NNP
cord-258230-s4ty52kb	65	23	/	/	SYM
cord-258230-s4ty52kb	65	24	ARB	ARB	NNP
cord-258230-s4ty52kb	65	25	with	with	IN
cord-258230-s4ty52kb	65	26	lower	low	JJR
cord-258230-s4ty52kb	65	27	odds	odd	NNS
cord-258230-s4ty52kb	65	28	of	of	IN
cord-258230-s4ty52kb	65	29	developing	develop	VBG
cord-258230-s4ty52kb	65	30	severe	severe	JJ
cord-258230-s4ty52kb	65	31	disease	disease	NN
cord-258230-s4ty52kb	65	32	vs.	vs.	FW
cord-258230-s4ty52kb	65	33	non	non	NNS
cord-258230-s4ty52kb	65	34	-	-	NNS
cord-258230-s4ty52kb	65	35	users	user	NNS
cord-258230-s4ty52kb	65	36	(	(	-LRB-
cord-258230-s4ty52kb	65	37	OR	or	CC
cord-258230-s4ty52kb	65	38	=	=	SYM
cord-258230-s4ty52kb	65	39	0.81	0.81	CD
cord-258230-s4ty52kb	65	40	,	,	,
cord-258230-s4ty52kb	65	41	95	95	CD
cord-258230-s4ty52kb	65	42	%	%	NN
cord-258230-s4ty52kb	65	43	CI	CI	NNP
cord-258230-s4ty52kb	65	44	0.41	0.41	CD
cord-258230-s4ty52kb	65	45	-	-	SYM
cord-258230-s4ty52kb	65	46	1.58	1.58	CD
cord-258230-s4ty52kb	65	47	,	,	,
cord-258230-s4ty52kb	65	48	I	i	NN
cord-258230-s4ty52kb	65	49	2	2	CD
cord-258230-s4ty52kb	65	50	=	=	SYM
cord-258230-s4ty52kb	65	51	50.52	50.52	CD
cord-258230-s4ty52kb	65	52	,	,	,
cord-258230-s4ty52kb	65	53	P	p	NN
cord-258230-s4ty52kb	65	54	-	-	HYPH
cord-258230-s4ty52kb	65	55	value	value	NN
cord-258230-s4ty52kb	65	56	=	=	SYM
cord-258230-s4ty52kb	65	57	0.53	0.53	CD
cord-258230-s4ty52kb	65	58	)	)	-RRB-
cord-258230-s4ty52kb	66	1	(	(	-LRB-
cord-258230-s4ty52kb	66	2	Figures	figure	NNS
cord-258230-s4ty52kb	66	3	2	2	CD
cord-258230-s4ty52kb	66	4	and	and	CC
cord-258230-s4ty52kb	66	5	3	3	CD
cord-258230-s4ty52kb	66	6	)	)	-RRB-
cord-258230-s4ty52kb	66	7	.	.	.
cord-258230-s4ty52kb	67	1	Similarly	similarly	RB
cord-258230-s4ty52kb	67	2	,	,	,
cord-258230-s4ty52kb	67	3	Reynolds	Reynolds	NNP
cord-258230-s4ty52kb	67	4	et	et	NNP
cord-258230-s4ty52kb	67	5	al	al	NNP
cord-258230-s4ty52kb	67	6	.	.	.
cord-258230-s4ty52kb	68	1	found	find	VBD
cord-258230-s4ty52kb	68	2	a	a	DT
cord-258230-s4ty52kb	68	3	slightly	slightly	RB
cord-258230-s4ty52kb	68	4	lower	low	JJR
cord-258230-s4ty52kb	68	5	rate	rate	NN
cord-258230-s4ty52kb	68	6	of	of	IN
cord-258230-s4ty52kb	68	7	severe	severe	JJ
cord-258230-s4ty52kb	68	8	outcomes	outcome	NNS
cord-258230-s4ty52kb	68	9	which	which	WDT
cord-258230-s4ty52kb	68	10	included	include	VBD
cord-258230-s4ty52kb	68	11	admission	admission	NN
cord-258230-s4ty52kb	68	12	to	to	IN
cord-258230-s4ty52kb	68	13	the	the	DT
cord-258230-s4ty52kb	68	14	ICU	ICU	NNP
cord-258230-s4ty52kb	68	15	,	,	,
cord-258230-s4ty52kb	68	16	the	the	DT
cord-258230-s4ty52kb	68	17	use	use	NN
cord-258230-s4ty52kb	68	18	of	of	IN
cord-258230-s4ty52kb	68	19	non	non	JJ
cord-258230-s4ty52kb	68	20	-	-	JJ
cord-258230-s4ty52kb	68	21	invasive	invasive	JJ
cord-258230-s4ty52kb	68	22	or	or	CC
cord-258230-s4ty52kb	68	23	invasive	invasive	JJ
cord-258230-s4ty52kb	68	24	mechanical	mechanical	JJ
cord-258230-s4ty52kb	68	25	ventilation	ventilation	NN
cord-258230-s4ty52kb	68	26	,	,	,
cord-258230-s4ty52kb	68	27	or	or	CC
cord-258230-s4ty52kb	68	28	death	death	NN
cord-258230-s4ty52kb	68	29	in	in	IN
cord-258230-s4ty52kb	68	30	patients	patient	NNS
cord-258230-s4ty52kb	68	31	on	on	IN
cord-258230-s4ty52kb	68	32	an	an	DT
cord-258230-s4ty52kb	68	33	ACEI	ACEI	NNP
cord-258230-s4ty52kb	68	34	/	/	SYM
cord-258230-s4ty52kb	68	35	ARB	arb	NN
cord-258230-s4ty52kb	68	36	(	(	-LRB-
cord-258230-s4ty52kb	68	37	24.8	24.8	CD
cord-258230-s4ty52kb	68	38	%	%	NN
cord-258230-s4ty52kb	68	39	)	)	-RRB-
cord-258230-s4ty52kb	68	40	vs.	vs.	FW
cord-258230-s4ty52kb	68	41	no	no	DT
cord-258230-s4ty52kb	68	42	ACEI	ACEI	NNP
cord-258230-s4ty52kb	68	43	/	/	SYM
cord-258230-s4ty52kb	68	44	ARB	ARB	NNP
cord-258230-s4ty52kb	68	45	(	(	-LRB-
cord-258230-s4ty52kb	68	46	24.9	24.9	CD
cord-258230-s4ty52kb	68	47	%	%	NN
cord-258230-s4ty52kb	68	48	)	)	-RRB-
cord-258230-s4ty52kb	68	49	14	14	CD
cord-258230-s4ty52kb	68	50	,	,	,
cord-258230-s4ty52kb	68	51	15	15	CD
cord-258230-s4ty52kb	68	52	,	,	,
cord-258230-s4ty52kb	68	53	[	[	-LRB-
cord-258230-s4ty52kb	68	54	17	17	CD
cord-258230-s4ty52kb	68	55	]	]	-RRB-
cord-258230-s4ty52kb	68	56	[	[	-LRB-
cord-258230-s4ty52kb	68	57	18	18	CD
cord-258230-s4ty52kb	68	58	]	]	-RRB-
cord-258230-s4ty52kb	68	59	[	[	-LRB-
cord-258230-s4ty52kb	68	60	19	19	CD
cord-258230-s4ty52kb	68	61	]	]	-RRB-
cord-258230-s4ty52kb	68	62	21	21	CD
cord-258230-s4ty52kb	68	63	,	,	,
cord-258230-s4ty52kb	68	64	22	22	CD
cord-258230-s4ty52kb	68	65	,	,	,
cord-258230-s4ty52kb	68	66	[	[	-LRB-
cord-258230-s4ty52kb	68	67	25	25	CD
cord-258230-s4ty52kb	68	68	]	]	-RRB-
cord-258230-s4ty52kb	68	69	[	[	-LRB-
cord-258230-s4ty52kb	68	70	26	26	CD
cord-258230-s4ty52kb	68	71	]	]	-RRB-
cord-258230-s4ty52kb	68	72	[	[	-LRB-
cord-258230-s4ty52kb	68	73	27	27	CD
cord-258230-s4ty52kb	68	74	]	]	-RRB-
cord-258230-s4ty52kb	68	75	[	[	-LRB-
cord-258230-s4ty52kb	68	76	28	28	CD
cord-258230-s4ty52kb	68	77	]	]	-RRB-
cord-258230-s4ty52kb	68	78	[	[	-LRB-
cord-258230-s4ty52kb	68	79	29	29	CD
cord-258230-s4ty52kb	68	80	]	]	-RRB-
cord-258230-s4ty52kb	69	1	(	(	-LRB-
cord-258230-s4ty52kb	69	2	Table	table	NN
cord-258230-s4ty52kb	69	3	2	2	CD
cord-258230-s4ty52kb	69	4	)	)	-RRB-
cord-258230-s4ty52kb	69	5	.	.	.
cord-258230-s4ty52kb	70	1	On	on	IN
cord-258230-s4ty52kb	70	2	the	the	DT
cord-258230-s4ty52kb	70	3	contrary	contrary	NN
cord-258230-s4ty52kb	70	4	,	,	,
cord-258230-s4ty52kb	70	5	Guo	Guo	NNP
cord-258230-s4ty52kb	70	6	Table	Table	NNP
cord-258230-s4ty52kb	70	7	2	2	CD
cord-258230-s4ty52kb	70	8	)	)	-RRB-
cord-258230-s4ty52kb	70	9	.	.	.
cord-258230-s4ty52kb	71	1	In	in	IN
cord-258230-s4ty52kb	71	2	a	a	DT
cord-258230-s4ty52kb	71	3	pooled	pool	VBN
cord-258230-s4ty52kb	71	4	analysis	analysis	NN
cord-258230-s4ty52kb	71	5	of	of	IN
cord-258230-s4ty52kb	71	6	six	six	CD
cord-258230-s4ty52kb	71	7	peer	peer	NN
cord-258230-s4ty52kb	71	8	-	-	HYPH
cord-258230-s4ty52kb	71	9	reviewed	review	VBN
cord-258230-s4ty52kb	71	10	studies	study	NNS
cord-258230-s4ty52kb	71	11	,	,	,
cord-258230-s4ty52kb	71	12	there	there	EX
cord-258230-s4ty52kb	71	13	was	be	VBD
cord-258230-s4ty52kb	71	14	a	a	DT
cord-258230-s4ty52kb	71	15	statistically	statistically	RB
cord-258230-s4ty52kb	71	16	non	non	JJ
cord-258230-s4ty52kb	71	17	-	-	JJ
cord-258230-s4ty52kb	71	18	significant	significant	JJ
cord-258230-s4ty52kb	71	19	association	association	NN
cord-258230-s4ty52kb	71	20	of	of	IN
cord-258230-s4ty52kb	71	21	ACEIs	acei	NNS
cord-258230-s4ty52kb	71	22	/	/	SYM
cord-258230-s4ty52kb	71	23	ARBs	arb	NNS
cord-258230-s4ty52kb	71	24	with	with	IN
cord-258230-s4ty52kb	71	25	lower	low	JJR
cord-258230-s4ty52kb	71	26	odds	odd	NNS
cord-258230-s4ty52kb	71	27	of	of	IN
cord-258230-s4ty52kb	71	28	mortality	mortality	NN
cord-258230-s4ty52kb	71	29	as	as	IN
cord-258230-s4ty52kb	71	30	compared	compare	VBN
cord-258230-s4ty52kb	71	31	with	with	IN
cord-258230-s4ty52kb	71	32	non	non	NNS
cord-258230-s4ty52kb	71	33	-	-	NNS
cord-258230-s4ty52kb	71	34	users	user	NNS
cord-258230-s4ty52kb	71	35	(	(	-LRB-
cord-258230-s4ty52kb	71	36	OR	or	CC
cord-258230-s4ty52kb	71	37	=	=	SYM
cord-258230-s4ty52kb	71	38	0.86	0.86	CD
cord-258230-s4ty52kb	71	39	,	,	,
cord-258230-s4ty52kb	71	40	95	95	CD
cord-258230-s4ty52kb	71	41	%	%	NN
cord-258230-s4ty52kb	72	1	CI	CI	NNP
cord-258230-s4ty52kb	72	2	=	=	NFP
cord-258230-s4ty52kb	73	1	0.53	0.53	CD
cord-258230-s4ty52kb	73	2	-	-	HYPH
cord-258230-s4ty52kb	73	3	1.41	1.41	CD
cord-258230-s4ty52kb	73	4	,	,	,
cord-258230-s4ty52kb	73	5	I	i	NN
cord-258230-s4ty52kb	73	6	2	2	CD
cord-258230-s4ty52kb	73	7	=	=	SYM
cord-258230-s4ty52kb	73	8	79.12	79.12	CD
cord-258230-s4ty52kb	73	9	,	,	,
cord-258230-s4ty52kb	73	10	P	p	NN
cord-258230-s4ty52kb	73	11	-	-	HYPH
cord-258230-s4ty52kb	73	12	value	value	NN
cord-258230-s4ty52kb	73	13	=	=	SYM
cord-258230-s4ty52kb	73	14	0.55	0.55	CD
cord-258230-s4ty52kb	73	15	)	)	-RRB-
cord-258230-s4ty52kb	74	1	(	(	-LRB-
cord-258230-s4ty52kb	74	2	Figures	figure	NNS
cord-258230-s4ty52kb	74	3	4	4	CD
cord-258230-s4ty52kb	74	4	and	and	CC
cord-258230-s4ty52kb	74	5	5	5	CD
cord-258230-s4ty52kb	74	6	)	)	-RRB-
cord-258230-s4ty52kb	75	1	The	the	DT
cord-258230-s4ty52kb	75	2	sensitivity	sensitivity	NN
cord-258230-s4ty52kb	75	3	of	of	IN
cord-258230-s4ty52kb	75	4	the	the	DT
cord-258230-s4ty52kb	75	5	pooled	pool	VBN
cord-258230-s4ty52kb	75	6	results	result	NNS
cord-258230-s4ty52kb	75	7	of	of	IN
cord-258230-s4ty52kb	75	8	clinical	clinical	JJ
cord-258230-s4ty52kb	75	9	severity	severity	NN
cord-258230-s4ty52kb	75	10	and	and	CC
cord-258230-s4ty52kb	75	11	mortality	mortality	NN
cord-258230-s4ty52kb	75	12	outcomes	outcome	NNS
cord-258230-s4ty52kb	75	13	to	to	IN
cord-258230-s4ty52kb	75	14	the	the	DT
cord-258230-s4ty52kb	75	15	removal	removal	NN
cord-258230-s4ty52kb	75	16	of	of	IN
cord-258230-s4ty52kb	75	17	each	each	DT
cord-258230-s4ty52kb	75	18	study	study	NN
cord-258230-s4ty52kb	75	19	is	be	VBZ
cord-258230-s4ty52kb	75	20	reported	report	VBN
cord-258230-s4ty52kb	75	21	in	in	IN
cord-258230-s4ty52kb	75	22	Supplementary	supplementary	JJ
cord-258230-s4ty52kb	75	23	material	material	NN
cord-258230-s4ty52kb	75	24	online	online	RB
cord-258230-s4ty52kb	75	25	,	,	,
cord-258230-s4ty52kb	75	26	Figures	figure	VBZ
cord-258230-s4ty52kb	75	27	S1-S4	S1-S4	NNP
cord-258230-s4ty52kb	75	28	.	.	.
cord-258230-s4ty52kb	76	1	Despite	despite	IN
cord-258230-s4ty52kb	76	2	the	the	DT
cord-258230-s4ty52kb	76	3	worldwide	worldwide	JJ
cord-258230-s4ty52kb	76	4	implementation	implementation	NN
cord-258230-s4ty52kb	76	5	of	of	IN
cord-258230-s4ty52kb	76	6	public	public	JJ
cord-258230-s4ty52kb	76	7	health	health	NN
cord-258230-s4ty52kb	76	8	measures	measure	NNS
cord-258230-s4ty52kb	76	9	such	such	JJ
cord-258230-s4ty52kb	76	10	as	as	IN
cord-258230-s4ty52kb	76	11	social	social	JJ
cord-258230-s4ty52kb	76	12	distancing	distancing	NN
cord-258230-s4ty52kb	76	13	,	,	,
cord-258230-s4ty52kb	76	14	contact	contact	NN
cord-258230-s4ty52kb	76	15	tracing	tracing	NN
cord-258230-s4ty52kb	76	16	,	,	,
cord-258230-s4ty52kb	76	17	and	and	CC
cord-258230-s4ty52kb	76	18	mass	mass	JJ
cord-258230-s4ty52kb	76	19	testing	testing	NN
cord-258230-s4ty52kb	76	20	to	to	TO
cord-258230-s4ty52kb	76	21	aid	aid	VB
cord-258230-s4ty52kb	76	22	in	in	IN
cord-258230-s4ty52kb	76	23	the	the	DT
cord-258230-s4ty52kb	76	24	control	control	NN
cord-258230-s4ty52kb	76	25	of	of	IN
cord-258230-s4ty52kb	76	26	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	76	27	,	,	,
cord-258230-s4ty52kb	76	28	the	the	DT
cord-258230-s4ty52kb	76	29	global	global	JJ
cord-258230-s4ty52kb	76	30	cases	case	NNS
cord-258230-s4ty52kb	76	31	have	have	VBP
cord-258230-s4ty52kb	76	32	risen	rise	VBN
cord-258230-s4ty52kb	76	33	to	to	IN
cord-258230-s4ty52kb	76	34	>	>	XX
cord-258230-s4ty52kb	76	35	3	3	CD
cord-258230-s4ty52kb	76	36	million	million	CD
cord-258230-s4ty52kb	76	37	,	,	,
cord-258230-s4ty52kb	76	38	and	and	CC
cord-258230-s4ty52kb	76	39	>	>	XX
cord-258230-s4ty52kb	76	40	200	200	CD
cord-258230-s4ty52kb	76	41	000	000	CD
cord-258230-s4ty52kb	76	42	patients	patient	NNS
cord-258230-s4ty52kb	76	43	had	have	VBD
cord-258230-s4ty52kb	76	44	lost	lose	VBN
cord-258230-s4ty52kb	76	45	their	-PRON-	PRP$
cord-258230-s4ty52kb	76	46	lives	life	NNS
cord-258230-s4ty52kb	76	47	by	by	IN
cord-258230-s4ty52kb	76	48	27	27	CD
cord-258230-s4ty52kb	76	49	April	April	NNP
cord-258230-s4ty52kb	76	50	2020	2020	CD
cord-258230-s4ty52kb	76	51	,	,	,
cord-258230-s4ty52kb	76	52	2,31	2,31	CD
cord-258230-s4ty52kb	76	53	which	which	WDT
cord-258230-s4ty52kb	76	54	further	further	RB
cord-258230-s4ty52kb	76	55	requires	require	VBZ
cord-258230-s4ty52kb	76	56	attention	attention	NN
cord-258230-s4ty52kb	76	57	.	.	.
cord-258230-s4ty52kb	77	1	Several	several	JJ
cord-258230-s4ty52kb	77	2	studies	study	NNS
cord-258230-s4ty52kb	77	3	have	have	VBP
cord-258230-s4ty52kb	77	4	reported	report	VBN
cord-258230-s4ty52kb	77	5	increased	increase	VBN
cord-258230-s4ty52kb	77	6	rates	rate	NNS
cord-258230-s4ty52kb	77	7	of	of	IN
cord-258230-s4ty52kb	77	8	COVID-19-associated	covid-19-associated	JJ
cord-258230-s4ty52kb	77	9	mortality	mortality	NN
cord-258230-s4ty52kb	77	10	in	in	IN
cord-258230-s4ty52kb	77	11	patients	patient	NNS
cord-258230-s4ty52kb	77	12	with	with	IN
cord-258230-s4ty52kb	77	13	significant	significant	JJ
cord-258230-s4ty52kb	77	14	comorbidities	comorbiditie	NNS
cord-258230-s4ty52kb	77	15	such	such	JJ
cord-258230-s4ty52kb	77	16	as	as	IN
cord-258230-s4ty52kb	77	17	hypertension	hypertension	NN
cord-258230-s4ty52kb	77	18	,	,	,
cord-258230-s4ty52kb	77	19	cardiovascular	cardiovascular	JJ
cord-258230-s4ty52kb	77	20	disease	disease	NN
cord-258230-s4ty52kb	77	21	,	,	,
cord-258230-s4ty52kb	77	22	chronic	chronic	JJ
cord-258230-s4ty52kb	77	23	kidney	kidney	NN
cord-258230-s4ty52kb	77	24	disease	disease	NN
cord-258230-s4ty52kb	77	25	,	,	,
cord-258230-s4ty52kb	77	26	or	or	CC
cord-258230-s4ty52kb	77	27	heart	heart	NN
cord-258230-s4ty52kb	77	28	failure	failure	NN
cord-258230-s4ty52kb	77	29	.	.	.
cord-258230-s4ty52kb	78	1	3	3	CD
cord-258230-s4ty52kb	78	2	,	,	,
cord-258230-s4ty52kb	78	3	4	4	CD
cord-258230-s4ty52kb	79	1	Although	although	IN
cord-258230-s4ty52kb	79	2	ACEIs	acei	NNS
cord-258230-s4ty52kb	79	3	and	and	CC
cord-258230-s4ty52kb	79	4	ARBs	arb	NNS
cord-258230-s4ty52kb	79	5	are	be	VBP
cord-258230-s4ty52kb	79	6	commonly	commonly	RB
cord-258230-s4ty52kb	79	7	prescribed	prescribe	VBN
cord-258230-s4ty52kb	79	8	to	to	TO
cord-258230-s4ty52kb	79	9	treat	treat	VB
cord-258230-s4ty52kb	79	10	some	some	DT
cord-258230-s4ty52kb	79	11	of	of	IN
cord-258230-s4ty52kb	79	12	these	these	DT
cord-258230-s4ty52kb	79	13	comorbidities	comorbiditie	NNS
cord-258230-s4ty52kb	79	14	,	,	,
cord-258230-s4ty52kb	79	15	the	the	DT
cord-258230-s4ty52kb	79	16	fact	fact	NN
cord-258230-s4ty52kb	79	17	that	that	IN
cord-258230-s4ty52kb	79	18	the	the	DT
cord-258230-s4ty52kb	79	19	ACE2	ACE2	NNP
cord-258230-s4ty52kb	79	20	receptor	receptor	NN
cord-258230-s4ty52kb	79	21	is	be	VBZ
cord-258230-s4ty52kb	79	22	the	the	DT
cord-258230-s4ty52kb	79	23	main	main	JJ
cord-258230-s4ty52kb	79	24	binding	binding	NN
cord-258230-s4ty52kb	79	25	site	site	NN
cord-258230-s4ty52kb	79	26	for	for	IN
cord-258230-s4ty52kb	79	27	entry	entry	NN
cord-258230-s4ty52kb	79	28	of	of	IN
cord-258230-s4ty52kb	79	29	SARS	SARS	NNP
cord-258230-s4ty52kb	79	30	-	-	HYPH
cord-258230-s4ty52kb	79	31	CoV-2	CoV-2	NNP
cord-258230-s4ty52kb	79	32	caused	cause	VBD
cord-258230-s4ty52kb	79	33	concerns	concern	NNS
cord-258230-s4ty52kb	79	34	regarding	regard	VBG
cord-258230-s4ty52kb	79	35	the	the	DT
cord-258230-s4ty52kb	79	36	use	use	NN
cord-258230-s4ty52kb	79	37	of	of	IN
cord-258230-s4ty52kb	79	38	ACEIs	acei	NNS
cord-258230-s4ty52kb	79	39	and	and	CC
cord-258230-s4ty52kb	79	40	ARBs	arb	NNS
cord-258230-s4ty52kb	79	41	in	in	IN
cord-258230-s4ty52kb	79	42	such	such	JJ
cord-258230-s4ty52kb	79	43	patients	patient	NNS
cord-258230-s4ty52kb	79	44	.	.	.
cord-258230-s4ty52kb	80	1	5	5	LS
cord-258230-s4ty52kb	81	1	,	,	,
cord-258230-s4ty52kb	81	2	32	32	CD
cord-258230-s4ty52kb	81	3	Several	several	JJ
cord-258230-s4ty52kb	81	4	evidence	evidence	NN
cord-258230-s4ty52kb	81	5	-	-	HYPH
cord-258230-s4ty52kb	81	6	based	base	VBN
cord-258230-s4ty52kb	81	7	consensus	consensus	NN
cord-258230-s4ty52kb	81	8	and	and	CC
cord-258230-s4ty52kb	81	9	position	position	NN
cord-258230-s4ty52kb	81	10	statements	statement	NNS
cord-258230-s4ty52kb	81	11	were	be	VBD
cord-258230-s4ty52kb	81	12	formulated	formulate	VBN
cord-258230-s4ty52kb	81	13	by	by	IN
cord-258230-s4ty52kb	81	14	various	various	JJ
cord-258230-s4ty52kb	81	15	cardiovascular	cardiovascular	NN
cord-258230-s4ty52kb	81	16	and	and	CC
cord-258230-s4ty52kb	81	17	hypertension	hypertension	NN
cord-258230-s4ty52kb	81	18	societies	society	NNS
cord-258230-s4ty52kb	81	19	which	which	WDT
cord-258230-s4ty52kb	81	20	recommended	recommend	VBD
cord-258230-s4ty52kb	81	21	continued	continued	JJ
cord-258230-s4ty52kb	81	22	use	use	NN
cord-258230-s4ty52kb	81	23	of	of	IN
cord-258230-s4ty52kb	81	24	ACEIs	acei	NNS
cord-258230-s4ty52kb	81	25	and	and	CC
cord-258230-s4ty52kb	81	26	ARBs	arb	NNS
cord-258230-s4ty52kb	81	27	in	in	IN
cord-258230-s4ty52kb	81	28	COVID-19	covid-19	CD
cord-258230-s4ty52kb	81	29	patients	patient	NNS
cord-258230-s4ty52kb	81	30	,	,	,
cord-258230-s4ty52kb	81	31	citing	cite	VBG
cord-258230-s4ty52kb	81	32	the	the	DT
cord-258230-s4ty52kb	81	33	lack	lack	NN
cord-258230-s4ty52kb	81	34	of	of	IN
cord-258230-s4ty52kb	81	35	any	any	DT
cord-258230-s4ty52kb	81	36	contrary	contrary	JJ
cord-258230-s4ty52kb	81	37	clinical	clinical	JJ
cord-258230-s4ty52kb	81	38	evidence	evidence	NN
cord-258230-s4ty52kb	81	39	.	.	.
cord-258230-s4ty52kb	82	1	[	[	-LRB-
cord-258230-s4ty52kb	82	2	8	8	CD
cord-258230-s4ty52kb	82	3	]	]	-RRB-
cord-258230-s4ty52kb	82	4	[	[	-LRB-
cord-258230-s4ty52kb	82	5	9	9	CD
cord-258230-s4ty52kb	82	6	]	]	-RRB-
cord-258230-s4ty52kb	82	7	[	[	-LRB-
cord-258230-s4ty52kb	82	8	10	10	CD
cord-258230-s4ty52kb	82	9	]	]	-RRB-
cord-258230-s4ty52kb	82	10	[	[	-LRB-
cord-258230-s4ty52kb	82	11	11	11	CD
cord-258230-s4ty52kb	82	12	]	]	-RRB-
cord-258230-s4ty52kb	83	1	[	[	-LRB-
cord-258230-s4ty52kb	83	2	12	12	CD
cord-258230-s4ty52kb	83	3	]	]	-RRB-
cord-258230-s4ty52kb	84	1	Since	since	IN
cord-258230-s4ty52kb	84	2	then	then	RB
cord-258230-s4ty52kb	84	3	,	,	,
cord-258230-s4ty52kb	84	4	however	however	RB
cord-258230-s4ty52kb	84	5	,	,	,
cord-258230-s4ty52kb	84	6	several	several	JJ
cord-258230-s4ty52kb	84	7	clinical	clinical	JJ
cord-258230-s4ty52kb	84	8	studies	study	NNS
cord-258230-s4ty52kb	84	9	have	have	VBP
cord-258230-s4ty52kb	84	10	evaluated	evaluate	VBN
cord-258230-s4ty52kb	84	11	the	the	DT
cord-258230-s4ty52kb	84	12	association	association	NN
cord-258230-s4ty52kb	84	13	of	of	IN
cord-258230-s4ty52kb	84	14	ACEIs	ACEIs	NNPS
cord-258230-s4ty52kb	84	15	and	and	CC
cord-258230-s4ty52kb	84	16	ARBs	arb	NNS
cord-258230-s4ty52kb	84	17	in	in	IN
cord-258230-s4ty52kb	84	18	COVID-19	covid-19	CD
cord-258230-s4ty52kb	84	19	patients	patient	NNS
cord-258230-s4ty52kb	84	20	and	and	CC
cord-258230-s4ty52kb	84	21	comorbidities	comorbiditie	NNS
cord-258230-s4ty52kb	84	22	.	.	.
cord-258230-s4ty52kb	85	1	It	-PRON-	PRP
cord-258230-s4ty52kb	85	2	is	be	VBZ
cord-258230-s4ty52kb	85	3	imperative	imperative	JJ
cord-258230-s4ty52kb	85	4	to	to	TO
cord-258230-s4ty52kb	85	5	accurately	accurately	RB
cord-258230-s4ty52kb	85	6	predict	predict	VB
cord-258230-s4ty52kb	85	7	clinical	clinical	JJ
cord-258230-s4ty52kb	85	8	outcomes	outcome	NNS
cord-258230-s4ty52kb	85	9	of	of	IN
cord-258230-s4ty52kb	85	10	COVID-19	covid-19	JJ
cord-258230-s4ty52kb	85	11	patients	patient	NNS
cord-258230-s4ty52kb	85	12	,	,	,
cord-258230-s4ty52kb	85	13	especially	especially	RB
cord-258230-s4ty52kb	85	14	those	those	DT
cord-258230-s4ty52kb	85	15	with	with	IN
cord-258230-s4ty52kb	85	16	comorbidities	comorbiditie	NNS
cord-258230-s4ty52kb	85	17	and	and	CC
cord-258230-s4ty52kb	85	18	taking	take	VBG
cord-258230-s4ty52kb	85	19	an	an	DT
cord-258230-s4ty52kb	85	20	ACEI	ACEI	NNP
cord-258230-s4ty52kb	85	21	or	or	CC
cord-258230-s4ty52kb	85	22	ARB	ARB	NNP
cord-258230-s4ty52kb	85	23	,	,	,
cord-258230-s4ty52kb	85	24	to	to	TO
cord-258230-s4ty52kb	85	25	decide	decide	VB
cord-258230-s4ty52kb	85	26	whether	whether	IN
cord-258230-s4ty52kb	85	27	to	to	TO
cord-258230-s4ty52kb	85	28	continue	continue	VB
cord-258230-s4ty52kb	85	29	or	or	CC
cord-258230-s4ty52kb	85	30	switch	switch	VB
cord-258230-s4ty52kb	85	31	to	to	IN
cord-258230-s4ty52kb	85	32	another	another	DT
cord-258230-s4ty52kb	85	33	medication	medication	NN
cord-258230-s4ty52kb	85	34	.	.	.
cord-258230-s4ty52kb	86	1	However	however	RB
cord-258230-s4ty52kb	86	2	,	,	,
cord-258230-s4ty52kb	86	3	there	there	EX
cord-258230-s4ty52kb	86	4	were	be	VBD
cord-258230-s4ty52kb	86	5	conflicting	conflict	VBG
cord-258230-s4ty52kb	86	6	findings	finding	NNS
cord-258230-s4ty52kb	86	7	reported	report	VBN
cord-258230-s4ty52kb	86	8	in	in	IN
cord-258230-s4ty52kb	86	9	several	several	JJ
cord-258230-s4ty52kb	86	10	studies	study	NNS
cord-258230-s4ty52kb	86	11	,	,	,
cord-258230-s4ty52kb	86	12	as	as	IN
cord-258230-s4ty52kb	86	13	Meng	Meng	NNP
cord-258230-s4ty52kb	86	14	(	(	-LRB-
cord-258230-s4ty52kb	86	15	Figures	figure	NNS
cord-258230-s4ty52kb	86	16	2	2	CD
cord-258230-s4ty52kb	86	17	and	and	CC
cord-258230-s4ty52kb	86	18	3	3	CD
cord-258230-s4ty52kb	86	19	)	)	-RRB-
cord-258230-s4ty52kb	86	20	.	.	.
cord-258230-s4ty52kb	87	1	ACEI	ACEI	NNP
cord-258230-s4ty52kb	87	2	and	and	CC
cord-258230-s4ty52kb	87	3	ARB	ARB	NNP
cord-258230-s4ty52kb	87	4	use	use	NN
cord-258230-s4ty52kb	87	5	in	in	IN
cord-258230-s4ty52kb	87	6	COVID-19	covid-19	JJ
cord-258230-s4ty52kb	87	7	patients	patient	NNS
cord-258230-s4ty52kb	87	8	mortality	mortality	NN
cord-258230-s4ty52kb	87	9	outcomes	outcome	NNS
cord-258230-s4ty52kb	87	10	,	,	,
cord-258230-s4ty52kb	87	11	strengthening	strengthen	VBG
cord-258230-s4ty52kb	87	12	their	-PRON-	PRP$
cord-258230-s4ty52kb	87	13	conclusions	conclusion	NNS
cord-258230-s4ty52kb	87	14	regarding	regard	VBG
cord-258230-s4ty52kb	87	15	safety	safety	NN
cord-258230-s4ty52kb	87	16	of	of	IN
cord-258230-s4ty52kb	87	17	ACEI	ACEI	NNP
cord-258230-s4ty52kb	87	18	/	/	SYM
cord-258230-s4ty52kb	87	19	ARB	ARB	NNP
cord-258230-s4ty52kb	87	20	use	use	NN
cord-258230-s4ty52kb	87	21	;	;	:
cord-258230-s4ty52kb	87	22	however	however	RB
cord-258230-s4ty52kb	87	23	,	,	,
cord-258230-s4ty52kb	87	24	a	a	DT
cord-258230-s4ty52kb	87	25	large	large	JJ
cord-258230-s4ty52kb	87	26	sample	sample	NN
cord-258230-s4ty52kb	87	27	size	size	NN
cord-258230-s4ty52kb	87	28	study	study	NN
cord-258230-s4ty52kb	87	29	conducted	conduct	VBN
cord-258230-s4ty52kb	87	30	in	in	IN
cord-258230-s4ty52kb	87	31	New	New	NNP
cord-258230-s4ty52kb	87	32	York	York	NNP
cord-258230-s4ty52kb	87	33	in	in	IN
cord-258230-s4ty52kb	87	34	>	>	XX
cord-258230-s4ty52kb	87	35	1000	1000	CD
cord-258230-s4ty52kb	87	36	COVID-19	covid-19	CD
cord-258230-s4ty52kb	87	37	patients	patient	NNS
cord-258230-s4ty52kb	87	38	by	by	IN
cord-258230-s4ty52kb	87	39	Richardson	Richardson	NNP
cord-258230-s4ty52kb	87	40	et	et	NNP
cord-258230-s4ty52kb	87	41	al	al	NNP
cord-258230-s4ty52kb	87	42	.	.	.
cord-258230-s4ty52kb	88	1	raised	raise	VBN
cord-258230-s4ty52kb	88	2	concerns	concern	NNS
cord-258230-s4ty52kb	88	3	of	of	IN
cord-258230-s4ty52kb	88	4	worse	bad	JJR
cord-258230-s4ty52kb	88	5	mortality	mortality	NN
cord-258230-s4ty52kb	88	6	outcomes	outcome	NNS
cord-258230-s4ty52kb	88	7	with	with	IN
cord-258230-s4ty52kb	88	8	ACEI	ACEI	NNP
cord-258230-s4ty52kb	88	9	/	/	SYM
cord-258230-s4ty52kb	88	10	ARB	ARB	NNP
cord-258230-s4ty52kb	88	11	use	use	NN
cord-258230-s4ty52kb	88	12	and	and	CC
cord-258230-s4ty52kb	88	13	can	can	MD
cord-258230-s4ty52kb	88	14	not	not	RB
cord-258230-s4ty52kb	88	15	be	be	VB
cord-258230-s4ty52kb	88	16	overlooked	overlook	VBN
cord-258230-s4ty52kb	88	17	.	.	.
cord-258230-s4ty52kb	89	1	15	15	CD
cord-258230-s4ty52kb	89	2	,	,	,
cord-258230-s4ty52kb	89	3	21	21	CD
cord-258230-s4ty52kb	90	1	In	in	IN
cord-258230-s4ty52kb	90	2	a	a	DT
cord-258230-s4ty52kb	90	3	pooled	pool	VBN
cord-258230-s4ty52kb	90	4	analysis	analysis	NN
cord-258230-s4ty52kb	90	5	of	of	IN
cord-258230-s4ty52kb	90	6	six	six	CD
cord-258230-s4ty52kb	90	7	peer	peer	NN
cord-258230-s4ty52kb	90	8	-	-	HYPH
cord-258230-s4ty52kb	90	9	reviewed	review	VBN
cord-258230-s4ty52kb	90	10	studies	study	NNS
cord-258230-s4ty52kb	90	11	,	,	,
cord-258230-s4ty52kb	90	12	there	there	EX
cord-258230-s4ty52kb	90	13	was	be	VBD
cord-258230-s4ty52kb	90	14	a	a	DT
cord-258230-s4ty52kb	90	15	statistically	statistically	RB
cord-258230-s4ty52kb	90	16	non	non	JJ
cord-258230-s4ty52kb	90	17	-	-	JJ
cord-258230-s4ty52kb	90	18	significant	significant	JJ
cord-258230-s4ty52kb	90	19	association	association	NN
cord-258230-s4ty52kb	90	20	of	of	IN
cord-258230-s4ty52kb	90	21	ACEI/	ACEI/	NNP
cord-258230-s4ty52kb	90	22	ARB	ARB	NNP
cord-258230-s4ty52kb	90	23	use	use	NN
cord-258230-s4ty52kb	90	24	with	with	IN
cord-258230-s4ty52kb	90	25	lower	low	JJR
cord-258230-s4ty52kb	90	26	odds	odd	NNS
cord-258230-s4ty52kb	90	27	of	of	IN
cord-258230-s4ty52kb	90	28	mortality	mortality	NN
cord-258230-s4ty52kb	90	29	as	as	IN
cord-258230-s4ty52kb	90	30	compared	compare	VBN
cord-258230-s4ty52kb	90	31	with	with	IN
cord-258230-s4ty52kb	90	32	non	non	NNS
cord-258230-s4ty52kb	90	33	-	-	NNS
cord-258230-s4ty52kb	90	34	users	user	NNS
cord-258230-s4ty52kb	90	35	(	(	-LRB-
cord-258230-s4ty52kb	90	36	OR	or	CC
cord-258230-s4ty52kb	90	37	=	=	SYM
cord-258230-s4ty52kb	90	38	0.86	0.86	CD
cord-258230-s4ty52kb	90	39	,	,	,
cord-258230-s4ty52kb	90	40	95	95	CD
cord-258230-s4ty52kb	90	41	%	%	NN
cord-258230-s4ty52kb	91	1	CI	CI	NNP
cord-258230-s4ty52kb	91	2	=	=	NFP
cord-258230-s4ty52kb	92	1	0.53	0.53	CD
cord-258230-s4ty52kb	92	2	-	-	HYPH
cord-258230-s4ty52kb	92	3	1.41	1.41	CD
cord-258230-s4ty52kb	92	4	,	,	,
cord-258230-s4ty52kb	92	5	I	i	NN
cord-258230-s4ty52kb	92	6	2	2	CD
cord-258230-s4ty52kb	92	7	=	=	SYM
cord-258230-s4ty52kb	92	8	79.12	79.12	CD
cord-258230-s4ty52kb	92	9	,	,	,
cord-258230-s4ty52kb	92	10	P	p	NN
cord-258230-s4ty52kb	92	11	-	-	HYPH
cord-258230-s4ty52kb	92	12	value	value	NN
cord-258230-s4ty52kb	92	13	=	=	SYM
cord-258230-s4ty52kb	92	14	0.55	0.55	CD
cord-258230-s4ty52kb	92	15	)	)	-RRB-
cord-258230-s4ty52kb	93	1	(	(	-LRB-
cord-258230-s4ty52kb	93	2	Figures	figure	NNS
cord-258230-s4ty52kb	93	3	4	4	CD
cord-258230-s4ty52kb	93	4	 	 	_SP
cord-258230-s4ty52kb	93	5	and	and	CC
cord-258230-s4ty52kb	93	6	5	5	CD
cord-258230-s4ty52kb	93	7	)	)	-RRB-
cord-258230-s4ty52kb	93	8	.	.	.
cord-258230-s4ty52kb	94	1	Several	several	JJ
cord-258230-s4ty52kb	94	2	hypotheses	hypothesis	NNS
cord-258230-s4ty52kb	94	3	have	have	VBP
cord-258230-s4ty52kb	94	4	been	be	VBN
cord-258230-s4ty52kb	94	5	put	put	VBN
cord-258230-s4ty52kb	94	6	forward	forward	RB
cord-258230-s4ty52kb	94	7	explaining	explain	VBG
cord-258230-s4ty52kb	94	8	the	the	DT
cord-258230-s4ty52kb	94	9	positive	positive	JJ
cord-258230-s4ty52kb	94	10	and	and	CC
cord-258230-s4ty52kb	94	11	negative	negative	JJ
cord-258230-s4ty52kb	94	12	aspects	aspect	NNS
cord-258230-s4ty52kb	94	13	of	of	IN
cord-258230-s4ty52kb	94	14	ACEI	ACEI	NNP
cord-258230-s4ty52kb	94	15	/	/	SYM
cord-258230-s4ty52kb	94	16	ARB	ARB	NNP
cord-258230-s4ty52kb	94	17	administration	administration	NN
cord-258230-s4ty52kb	94	18	in	in	IN
cord-258230-s4ty52kb	94	19	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	94	20	patients	patient	NNS
cord-258230-s4ty52kb	94	21	.	.	.
cord-258230-s4ty52kb	95	1	Positive	positive	JJ
cord-258230-s4ty52kb	95	2	effects	effect	NNS
cord-258230-s4ty52kb	95	3	include	include	VBP
cord-258230-s4ty52kb	95	4	ACE2	ACE2	NNP
cord-258230-s4ty52kb	95	5	receptor	receptor	NN
cord-258230-s4ty52kb	95	6	blockade	blockade	NN
cord-258230-s4ty52kb	95	7	,	,	,
cord-258230-s4ty52kb	95	8	disabling	disable	VBG
cord-258230-s4ty52kb	95	9	viral	viral	JJ
cord-258230-s4ty52kb	95	10	entry	entry	NN
cord-258230-s4ty52kb	95	11	into	into	IN
cord-258230-s4ty52kb	95	12	the	the	DT
cord-258230-s4ty52kb	95	13	heart	heart	NN
cord-258230-s4ty52kb	95	14	and	and	CC
cord-258230-s4ty52kb	95	15	lungs	lung	NNS
cord-258230-s4ty52kb	95	16	,	,	,
cord-258230-s4ty52kb	95	17	and	and	CC
cord-258230-s4ty52kb	95	18	an	an	DT
cord-258230-s4ty52kb	95	19	overall	overall	JJ
cord-258230-s4ty52kb	95	20	decrease	decrease	NN
cord-258230-s4ty52kb	95	21	in	in	IN
cord-258230-s4ty52kb	95	22	inflammation	inflammation	NN
cord-258230-s4ty52kb	95	23	secondary	secondary	JJ
cord-258230-s4ty52kb	95	24	to	to	IN
cord-258230-s4ty52kb	95	25	ACEIs	acei	NNS
cord-258230-s4ty52kb	95	26	/	/	SYM
cord-258230-s4ty52kb	95	27	ARBs	arb	NNS
cord-258230-s4ty52kb	95	28	,	,	,
cord-258230-s4ty52kb	95	29	suggesting	suggest	VBG
cord-258230-s4ty52kb	95	30	that	that	IN
cord-258230-s4ty52kb	95	31	the	the	DT
cord-258230-s4ty52kb	95	32	use	use	NN
cord-258230-s4ty52kb	95	33	of	of	IN
cord-258230-s4ty52kb	95	34	an	an	DT
cord-258230-s4ty52kb	95	35	ACEI	ACEI	NNP
cord-258230-s4ty52kb	95	36	might	may	MD
cord-258230-s4ty52kb	95	37	be	be	VB
cord-258230-s4ty52kb	95	38	protective	protective	JJ
cord-258230-s4ty52kb	95	39	against	against	IN
cord-258230-s4ty52kb	95	40	respiratory	respiratory	JJ
cord-258230-s4ty52kb	95	41	complications	complication	NNS
cord-258230-s4ty52kb	95	42	.	.	.
cord-258230-s4ty52kb	96	1	Negative	negative	JJ
cord-258230-s4ty52kb	96	2	effects	effect	NNS
cord-258230-s4ty52kb	96	3	include	include	VBP
cord-258230-s4ty52kb	96	4	a	a	DT
cord-258230-s4ty52kb	96	5	possible	possible	JJ
cord-258230-s4ty52kb	96	6	retrograde	retrograde	JJ
cord-258230-s4ty52kb	96	7	feedback	feedback	NN
cord-258230-s4ty52kb	96	8	mechanism	mechanism	NN
cord-258230-s4ty52kb	96	9	,	,	,
cord-258230-s4ty52kb	96	10	by	by	IN
cord-258230-s4ty52kb	96	11	which	which	WDT
cord-258230-s4ty52kb	96	12	ACE2	ACE2	NNP
cord-258230-s4ty52kb	96	13	receptors	receptor	NNS
cord-258230-s4ty52kb	96	14	are	be	VBP
cord-258230-s4ty52kb	96	15	up	up	RB
cord-258230-s4ty52kb	96	16	-	-	HYPH
cord-258230-s4ty52kb	96	17	regulated	regulate	VBN
cord-258230-s4ty52kb	96	18	,	,	,
cord-258230-s4ty52kb	96	19	which	which	WDT
cord-258230-s4ty52kb	96	20	may	may	MD
cord-258230-s4ty52kb	96	21	lead	lead	VB
cord-258230-s4ty52kb	96	22	to	to	IN
cord-258230-s4ty52kb	96	23	severe	severe	JJ
cord-258230-s4ty52kb	96	24	pneumonia	pneumonia	NN
cord-258230-s4ty52kb	96	25	,	,	,
cord-258230-s4ty52kb	96	26	increasing	increase	VBG
cord-258230-s4ty52kb	96	27	the	the	DT
cord-258230-s4ty52kb	96	28	risk	risk	NN
cord-258230-s4ty52kb	96	29	of	of	IN
cord-258230-s4ty52kb	96	30	severe	severe	JJ
cord-258230-s4ty52kb	96	31	outcomes	outcome	NNS
cord-258230-s4ty52kb	96	32	and	and	CC
cord-258230-s4ty52kb	96	33	mortality	mortality	NN
cord-258230-s4ty52kb	96	34	.	.	.
cord-258230-s4ty52kb	97	1	33	33	CD
cord-258230-s4ty52kb	97	2	Individuals	individual	NNS
cord-258230-s4ty52kb	97	3	with	with	IN
cord-258230-s4ty52kb	97	4	ACE2	ACE2	NNP
cord-258230-s4ty52kb	97	5	polymorphisms	polymorphism	NNS
cord-258230-s4ty52kb	97	6	have	have	VBP
cord-258230-s4ty52kb	97	7	an	an	DT
cord-258230-s4ty52kb	97	8	increased	increase	VBN
cord-258230-s4ty52kb	97	9	genetic	genetic	JJ
cord-258230-s4ty52kb	97	10	predisposition	predisposition	NN
cord-258230-s4ty52kb	97	11	for	for	IN
cord-258230-s4ty52kb	97	12	an	an	DT
cord-258230-s4ty52kb	97	13	increased	increase	VBN
cord-258230-s4ty52kb	97	14	risk	risk	NN
cord-258230-s4ty52kb	97	15	of	of	IN
cord-258230-s4ty52kb	97	16	SARS	SARS	NNP
cord-258230-s4ty52kb	97	17	-	-	HYPH
cord-258230-s4ty52kb	97	18	CoV-2	CoV-2	NNP
cord-258230-s4ty52kb	97	19	infection	infection	NN
cord-258230-s4ty52kb	97	20	and	and	CC
cord-258230-s4ty52kb	97	21	may	may	MD
cord-258230-s4ty52kb	97	22	have	have	VB
cord-258230-s4ty52kb	97	23	harmful	harmful	JJ
cord-258230-s4ty52kb	97	24	effects	effect	NNS
cord-258230-s4ty52kb	97	25	of	of	IN
cord-258230-s4ty52kb	97	26	ACEIs	acei	NNS
cord-258230-s4ty52kb	97	27	/	/	SYM
cord-258230-s4ty52kb	97	28	ARBs	arb	NNS
cord-258230-s4ty52kb	97	29	.	.	.
cord-258230-s4ty52kb	98	1	34	34	CD
cord-258230-s4ty52kb	99	1	This	this	DT
cord-258230-s4ty52kb	99	2	aspect	aspect	NN
cord-258230-s4ty52kb	99	3	is	be	VBZ
cord-258230-s4ty52kb	99	4	worth	worth	JJ
cord-258230-s4ty52kb	99	5	considering	consider	VBG
cord-258230-s4ty52kb	99	6	and	and	CC
cord-258230-s4ty52kb	99	7	needs	need	VBZ
cord-258230-s4ty52kb	99	8	to	to	TO
cord-258230-s4ty52kb	99	9	be	be	VB
cord-258230-s4ty52kb	99	10	evaluated	evaluate	VBN
cord-258230-s4ty52kb	99	11	in	in	IN
cord-258230-s4ty52kb	99	12	future	future	JJ
cord-258230-s4ty52kb	99	13	studies	study	NNS
cord-258230-s4ty52kb	99	14	.	.	.
cord-258230-s4ty52kb	100	1	To	to	IN
cord-258230-s4ty52kb	100	2	the	the	DT
cord-258230-s4ty52kb	100	3	best	good	JJS
cord-258230-s4ty52kb	100	4	of	of	IN
cord-258230-s4ty52kb	100	5	our	-PRON-	PRP$
cord-258230-s4ty52kb	100	6	knowledge	knowledge	NN
cord-258230-s4ty52kb	100	7	,	,	,
cord-258230-s4ty52kb	100	8	this	this	DT
cord-258230-s4ty52kb	100	9	systematic	systematic	JJ
cord-258230-s4ty52kb	100	10	review	review	NN
cord-258230-s4ty52kb	100	11	is	be	VBZ
cord-258230-s4ty52kb	100	12	a	a	DT
cord-258230-s4ty52kb	100	13	comprehensive	comprehensive	JJ
cord-258230-s4ty52kb	100	14	exploration	exploration	NN
cord-258230-s4ty52kb	100	15	and	and	CC
cord-258230-s4ty52kb	100	16	analysis	analysis	NN
cord-258230-s4ty52kb	100	17	of	of	IN
cord-258230-s4ty52kb	100	18	existing	exist	VBG
cord-258230-s4ty52kb	100	19	literature	literature	NN
cord-258230-s4ty52kb	100	20	in	in	IN
cord-258230-s4ty52kb	100	21	this	this	DT
cord-258230-s4ty52kb	100	22	topic	topic	NN
cord-258230-s4ty52kb	100	23	to	to	IN
cord-258230-s4ty52kb	100	24	date	date	NN
cord-258230-s4ty52kb	100	25	.	.	.
cord-258230-s4ty52kb	101	1	Our	-PRON-	PRP$
cord-258230-s4ty52kb	101	2	review	review	NN
cord-258230-s4ty52kb	101	3	has	have	VBZ
cord-258230-s4ty52kb	101	4	limitations	limitation	NNS
cord-258230-s4ty52kb	101	5	in	in	IN
cord-258230-s4ty52kb	101	6	its	-PRON-	PRP$
cord-258230-s4ty52kb	101	7	rigour	rigour	NN
cord-258230-s4ty52kb	101	8	due	due	IN
cord-258230-s4ty52kb	101	9	to	to	IN
cord-258230-s4ty52kb	101	10	the	the	DT
cord-258230-s4ty52kb	101	11	scarce	scarce	JJ
cord-258230-s4ty52kb	101	12	existing	exist	VBG
cord-258230-s4ty52kb	101	13	data	datum	NNS
cord-258230-s4ty52kb	101	14	and	and	CC
cord-258230-s4ty52kb	101	15	diverse	diverse	JJ
cord-258230-s4ty52kb	101	16	study	study	NN
cord-258230-s4ty52kb	101	17	types	type	NNS
cord-258230-s4ty52kb	101	18	available	available	JJ
cord-258230-s4ty52kb	101	19	.	.	.
cord-258230-s4ty52kb	102	1	The	the	DT
cord-258230-s4ty52kb	102	2	rapidly	rapidly	RB
cord-258230-s4ty52kb	102	3	emerging	emerge	VBG
cord-258230-s4ty52kb	102	4	knowledge	knowledge	NN
cord-258230-s4ty52kb	102	5	base	base	NN
cord-258230-s4ty52kb	102	6	of	of	IN
cord-258230-s4ty52kb	102	7	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	102	8	presents	present	VBZ
cord-258230-s4ty52kb	102	9	the	the	DT
cord-258230-s4ty52kb	102	10	possibility	possibility	NN
cord-258230-s4ty52kb	102	11	that	that	IN
cord-258230-s4ty52kb	102	12	a	a	DT
cord-258230-s4ty52kb	102	13	few	few	JJ
cord-258230-s4ty52kb	102	14	studies	study	NNS
cord-258230-s4ty52kb	102	15	(	(	-LRB-
cord-258230-s4ty52kb	102	16	particularly	particularly	RB
cord-258230-s4ty52kb	102	17	unpublished	unpublished	JJ
cord-258230-s4ty52kb	102	18	/	/	SYM
cord-258230-s4ty52kb	102	19	under	under	IN
cord-258230-s4ty52kb	102	20	peer	peer	NN
cord-258230-s4ty52kb	102	21	review	review	NN
cord-258230-s4ty52kb	102	22	)	)	-RRB-
cord-258230-s4ty52kb	102	23	remain	remain	VBP
cord-258230-s4ty52kb	102	24	uncaptured	uncaptured	JJ
cord-258230-s4ty52kb	102	25	.	.	.
cord-258230-s4ty52kb	103	1	However	however	RB
cord-258230-s4ty52kb	103	2	,	,	,
cord-258230-s4ty52kb	103	3	we	-PRON-	PRP
cord-258230-s4ty52kb	103	4	have	have	VBP
cord-258230-s4ty52kb	103	5	tried	try	VBN
cord-258230-s4ty52kb	103	6	our	-PRON-	PRP$
cord-258230-s4ty52kb	103	7	best	good	JJS
cord-258230-s4ty52kb	103	8	to	to	TO
cord-258230-s4ty52kb	103	9	mitigate	mitigate	VB
cord-258230-s4ty52kb	103	10	this	this	DT
cord-258230-s4ty52kb	103	11	by	by	IN
cord-258230-s4ty52kb	103	12	allowing	allow	VBG
cord-258230-s4ty52kb	103	13	broad	broad	JJ
cord-258230-s4ty52kb	103	14	search	search	NN
cord-258230-s4ty52kb	103	15	terms	term	NNS
cord-258230-s4ty52kb	103	16	and	and	CC
cord-258230-s4ty52kb	103	17	by	by	IN
cord-258230-s4ty52kb	103	18	including	include	VBG
cord-258230-s4ty52kb	103	19	many	many	JJ
cord-258230-s4ty52kb	103	20	databases	database	NNS
cord-258230-s4ty52kb	103	21	and	and	CC
cord-258230-s4ty52kb	103	22	repositories	repository	NNS
cord-258230-s4ty52kb	103	23	.	.	.
cord-258230-s4ty52kb	104	1	We	-PRON-	PRP
cord-258230-s4ty52kb	104	2	have	have	VBP
cord-258230-s4ty52kb	104	3	also	also	RB
cord-258230-s4ty52kb	104	4	tried	try	VBN
cord-258230-s4ty52kb	104	5	to	to	TO
cord-258230-s4ty52kb	104	6	comprehensively	comprehensively	RB
cord-258230-s4ty52kb	104	7	review	review	VB
cord-258230-s4ty52kb	104	8	and	and	CC
cord-258230-s4ty52kb	104	9	analyse	analyse	VB
cord-258230-s4ty52kb	104	10	the	the	DT
cord-258230-s4ty52kb	104	11	existing	exist	VBG
cord-258230-s4ty52kb	104	12	data	datum	NNS
cord-258230-s4ty52kb	104	13	.	.	.
cord-258230-s4ty52kb	105	1	Considering	consider	VBG
cord-258230-s4ty52kb	105	2	the	the	DT
cord-258230-s4ty52kb	105	3	inconsistent	inconsistent	JJ
cord-258230-s4ty52kb	105	4	clinical	clinical	JJ
cord-258230-s4ty52kb	105	5	studies	study	NNS
cord-258230-s4ty52kb	105	6	and	and	CC
cord-258230-s4ty52kb	105	7	conflicting	conflict	VBG
cord-258230-s4ty52kb	105	8	hypotheses	hypothesis	NNS
cord-258230-s4ty52kb	105	9	,	,	,
cord-258230-s4ty52kb	105	10	it	-PRON-	PRP
cord-258230-s4ty52kb	105	11	is	be	VBZ
cord-258230-s4ty52kb	105	12	essential	essential	JJ
cord-258230-s4ty52kb	105	13	to	to	TO
cord-258230-s4ty52kb	105	14	evaluate	evaluate	VB
cord-258230-s4ty52kb	105	15	the	the	DT
cord-258230-s4ty52kb	105	16	clinical	clinical	JJ
cord-258230-s4ty52kb	105	17	outcomes	outcome	NNS
cord-258230-s4ty52kb	105	18	in	in	IN
cord-258230-s4ty52kb	105	19	COVID-19	covid-19	JJ
cord-258230-s4ty52kb	105	20	patients	patient	NNS
cord-258230-s4ty52kb	105	21	on	on	IN
cord-258230-s4ty52kb	105	22	ACEIs	acei	NNS
cord-258230-s4ty52kb	105	23	/	/	SYM
cord-258230-s4ty52kb	105	24	ARBs	arb	NNS
cord-258230-s4ty52kb	105	25	in	in	IN
cord-258230-s4ty52kb	105	26	future	future	JJ
cord-258230-s4ty52kb	105	27	large	large	JJ
cord-258230-s4ty52kb	105	28	studies	study	NNS
cord-258230-s4ty52kb	105	29	,	,	,
cord-258230-s4ty52kb	105	30	particularly	particularly	RB
cord-258230-s4ty52kb	105	31	randomized	randomize	VBN
cord-258230-s4ty52kb	105	32	controlled	control	VBN
cord-258230-s4ty52kb	105	33	trials	trial	NNS
cord-258230-s4ty52kb	105	34	,	,	,
cord-258230-s4ty52kb	105	35	and	and	CC
cord-258230-s4ty52kb	105	36	additionally	additionally	RB
cord-258230-s4ty52kb	105	37	evaluate	evaluate	VB
cord-258230-s4ty52kb	105	38	the	the	DT
cord-258230-s4ty52kb	105	39	association	association	NN
cord-258230-s4ty52kb	105	40	of	of	IN
cord-258230-s4ty52kb	105	41	clinical	clinical	JJ
cord-258230-s4ty52kb	105	42	outcomes	outcome	NNS
cord-258230-s4ty52kb	105	43	with	with	IN
cord-258230-s4ty52kb	105	44	ACE2	ACE2	NNP
cord-258230-s4ty52kb	105	45	polymorphisms	polymorphism	NNS
cord-258230-s4ty52kb	105	46	.	.	.
cord-258230-s4ty52kb	106	1	Based	base	VBN
cord-258230-s4ty52kb	106	2	on	on	IN
cord-258230-s4ty52kb	106	3	this	this	DT
cord-258230-s4ty52kb	106	4	,	,	,
cord-258230-s4ty52kb	106	5	there	there	EX
cord-258230-s4ty52kb	106	6	are	be	VBP
cord-258230-s4ty52kb	106	7	ongoing	ongoing	JJ
cord-258230-s4ty52kb	106	8	trials	trial	NNS
cord-258230-s4ty52kb	106	9	studying	study	VBG
cord-258230-s4ty52kb	106	10	the	the	DT
cord-258230-s4ty52kb	106	11	effect	effect	NN
cord-258230-s4ty52kb	106	12	of	of	IN
cord-258230-s4ty52kb	106	13	losartan	losartan	NNP
cord-258230-s4ty52kb	106	14	(	(	-LRB-
cord-258230-s4ty52kb	106	15	an	an	DT
cord-258230-s4ty52kb	106	16	ARB	ARB	NNP
cord-258230-s4ty52kb	106	17	)	)	-RRB-
cord-258230-s4ty52kb	106	18	in	in	IN
cord-258230-s4ty52kb	106	19	patients	patient	NNS
cord-258230-s4ty52kb	106	20	with	with	IN
cord-258230-s4ty52kb	106	21	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	106	22	in	in	IN
cord-258230-s4ty52kb	106	23	outpatient	outpatient	NN
cord-258230-s4ty52kb	106	24	and	and	CC
cord-258230-s4ty52kb	106	25	inpatient	inpatient	JJ
cord-258230-s4ty52kb	106	26	settings	setting	NNS
cord-258230-s4ty52kb	106	27	(	(	-LRB-
cord-258230-s4ty52kb	106	28	NCT04311177	NCT04311177	NNP
cord-258230-s4ty52kb	106	29	and	and	CC
cord-258230-s4ty52kb	106	30	NCT04312009	NCT04312009	NNP
cord-258230-s4ty52kb	106	31	)	)	-RRB-
cord-258230-s4ty52kb	106	32	.	.	.
cord-258230-s4ty52kb	107	1	35	35	CD
cord-258230-s4ty52kb	107	2	,	,	,
cord-258230-s4ty52kb	107	3	36	36	CD
cord-258230-s4ty52kb	107	4	Conclusion	conclusion	NN
cord-258230-s4ty52kb	108	1	It	-PRON-	PRP
cord-258230-s4ty52kb	108	2	is	be	VBZ
cord-258230-s4ty52kb	108	3	concluded	conclude	VBN
cord-258230-s4ty52kb	108	4	that	that	IN
cord-258230-s4ty52kb	108	5	ACEIs	acei	NNS
cord-258230-s4ty52kb	108	6	and	and	CC
cord-258230-s4ty52kb	108	7	ARBs	arb	NNS
cord-258230-s4ty52kb	108	8	should	should	MD
cord-258230-s4ty52kb	108	9	be	be	VB
cord-258230-s4ty52kb	108	10	continued	continue	VBN
cord-258230-s4ty52kb	108	11	in	in	IN
cord-258230-s4ty52kb	108	12	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	108	13	patients	patient	NNS
cord-258230-s4ty52kb	108	14	,	,	,
cord-258230-s4ty52kb	108	15	reinforcing	reinforce	VBG
cord-258230-s4ty52kb	108	16	the	the	DT
cord-258230-s4ty52kb	108	17	recommendations	recommendation	NNS
cord-258230-s4ty52kb	108	18	made	make	VBN
cord-258230-s4ty52kb	108	19	by	by	IN
cord-258230-s4ty52kb	108	20	several	several	JJ
cord-258230-s4ty52kb	108	21	medical	medical	JJ
cord-258230-s4ty52kb	108	22	societies	society	NNS
cord-258230-s4ty52kb	108	23	.	.	.
cord-258230-s4ty52kb	109	1	Additionally	additionally	RB
cord-258230-s4ty52kb	109	2	,	,	,
cord-258230-s4ty52kb	109	3	the	the	DT
cord-258230-s4ty52kb	109	4	individual	individual	JJ
cord-258230-s4ty52kb	109	5	patient	patient	NN
cord-258230-s4ty52kb	109	6	factors	factor	NNS
cord-258230-s4ty52kb	109	7	such	such	JJ
cord-258230-s4ty52kb	109	8	as	as	IN
cord-258230-s4ty52kb	109	9	ACE2	ACE2	NNP
cord-258230-s4ty52kb	109	10	polymorphisms	polymorphism	NNS
cord-258230-s4ty52kb	109	11	which	which	WDT
cord-258230-s4ty52kb	109	12	might	may	MD
cord-258230-s4ty52kb	109	13	confer	confer	VB
cord-258230-s4ty52kb	109	14	higher	high	JJR
cord-258230-s4ty52kb	109	15	risk	risk	NN
cord-258230-s4ty52kb	109	16	of	of	IN
cord-258230-s4ty52kb	109	17	adverse	adverse	JJ
cord-258230-s4ty52kb	109	18	outcomes	outcome	NNS
cord-258230-s4ty52kb	109	19	need	need	VBP
cord-258230-s4ty52kb	109	20	to	to	TO
cord-258230-s4ty52kb	109	21	be	be	VB
cord-258230-s4ty52kb	109	22	evaluated	evaluate	VBN
cord-258230-s4ty52kb	109	23	further	further	RB
cord-258230-s4ty52kb	109	24	.	.	.
cord-258230-s4ty52kb	110	1	A.G.	A.G.	NNP
cord-258230-s4ty52kb	110	2	:	:	:
cord-258230-s4ty52kb	110	3	conception	conception	NN
cord-258230-s4ty52kb	110	4	and	and	CC
cord-258230-s4ty52kb	110	5	design	design	NN
cord-258230-s4ty52kb	110	6	,	,	,
cord-258230-s4ty52kb	110	7	data	datum	NNS
cord-258230-s4ty52kb	110	8	acquisition	acquisition	NN
cord-258230-s4ty52kb	110	9	and	and	CC
cord-258230-s4ty52kb	110	10	analysis	analysis	NN
cord-258230-s4ty52kb	110	11	,	,	,
cord-258230-s4ty52kb	110	12	drafting	draft	VBG
cord-258230-s4ty52kb	110	13	the	the	DT
cord-258230-s4ty52kb	110	14	manuscript	manuscript	NN
cord-258230-s4ty52kb	110	15	,	,	,
cord-258230-s4ty52kb	110	16	and	and	CC
cord-258230-s4ty52kb	110	17	final	final	JJ
cord-258230-s4ty52kb	110	18	approval	approval	NN
cord-258230-s4ty52kb	110	19	of	of	IN
cord-258230-s4ty52kb	110	20	the	the	DT
cord-258230-s4ty52kb	110	21	manuscript	manuscript	NN
cord-258230-s4ty52kb	110	22	.	.	.
cord-258230-s4ty52kb	111	1	M.O.	M.O.	NNP
cord-258230-s4ty52kb	111	2	:	:	:
cord-258230-s4ty52kb	111	3	data	datum	NNS
cord-258230-s4ty52kb	111	4	acquisition	acquisition	NN
cord-258230-s4ty52kb	111	5	,	,	,
cord-258230-s4ty52kb	111	6	drafting	draft	VBG
cord-258230-s4ty52kb	111	7	and	and	CC
cord-258230-s4ty52kb	111	8	final	final	JJ
cord-258230-s4ty52kb	111	9	approval	approval	NN
cord-258230-s4ty52kb	111	10	of	of	IN
cord-258230-s4ty52kb	111	11	the	the	DT
cord-258230-s4ty52kb	111	12	manuscript	manuscript	NN
cord-258230-s4ty52kb	111	13	.	.	.
cord-258230-s4ty52kb	112	1	Supplementary	supplementary	JJ
cord-258230-s4ty52kb	112	2	material	material	NN
cord-258230-s4ty52kb	112	3	is	be	VBZ
cord-258230-s4ty52kb	112	4	available	available	JJ
cord-258230-s4ty52kb	112	5	at	at	IN
cord-258230-s4ty52kb	112	6	European	European	NNP
cord-258230-s4ty52kb	112	7	Heart	Heart	NNP
cord-258230-s4ty52kb	112	8	Journal	Journal	NNP
cord-258230-s4ty52kb	112	9	-Cardiovascular	-Cardiovascular	.
cord-258230-s4ty52kb	113	1	Pharmacotherapy	Pharmacotherapy	NNP
cord-258230-s4ty52kb	113	2	online	online	RB
cord-258230-s4ty52kb	113	3	.	.	.
cord-258230-s4ty52kb	114	1	Outbreak	outbreak	NN
cord-258230-s4ty52kb	114	2	of	of	IN
cord-258230-s4ty52kb	114	3	a	a	DT
cord-258230-s4ty52kb	114	4	novel	novel	JJ
cord-258230-s4ty52kb	114	5	coronavirus	coronavirus	NN
cord-258230-s4ty52kb	114	6	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	114	7	Map	Map	NNP
cord-258230-s4ty52kb	114	8	-Johns	-johns	WDT
cord-258230-s4ty52kb	114	9	Hopkins	Hopkins	NNP
cord-258230-s4ty52kb	114	10	Coronavirus	Coronavirus	NNP
cord-258230-s4ty52kb	114	11	Resource	Resource	NNP
cord-258230-s4ty52kb	114	12	Cente	Cente	NNP
cord-258230-s4ty52kb	114	13	Prevalence	prevalence	NN
cord-258230-s4ty52kb	114	14	and	and	CC
cord-258230-s4ty52kb	114	15	impact	impact	NN
cord-258230-s4ty52kb	114	16	of	of	IN
cord-258230-s4ty52kb	114	17	cardiovascular	cardiovascular	JJ
cord-258230-s4ty52kb	114	18	metabolic	metabolic	JJ
cord-258230-s4ty52kb	114	19	diseases	disease	NNS
cord-258230-s4ty52kb	114	20	on	on	IN
cord-258230-s4ty52kb	114	21	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	114	22	in	in	IN
cord-258230-s4ty52kb	114	23	China	China	NNP
cord-258230-s4ty52kb	115	1	Renin	renin	NN
cord-258230-s4ty52kb	115	2	-	-	HYPH
cord-258230-s4ty52kb	115	3	angiotensin	angiotensin	NN
cord-258230-s4ty52kb	115	4	-	-	HYPH
cord-258230-s4ty52kb	115	5	aldosterone	aldosterone	NN
cord-258230-s4ty52kb	115	6	system	system	NN
cord-258230-s4ty52kb	115	7	inhibitors	inhibitor	NNS
cord-258230-s4ty52kb	115	8	in	in	IN
cord-258230-s4ty52kb	115	9	patients	patient	NNS
cord-258230-s4ty52kb	115	10	with	with	IN
cord-258230-s4ty52kb	115	11	Covid-19	Covid-19	NNP
cord-258230-s4ty52kb	115	12	Ambiguities	Ambiguities	NNPS
cord-258230-s4ty52kb	115	13	in	in	IN
cord-258230-s4ty52kb	115	14	the	the	DT
cord-258230-s4ty52kb	115	15	guidelines	guideline	NNS
cord-258230-s4ty52kb	115	16	for	for	IN
cord-258230-s4ty52kb	115	17	the	the	DT
cord-258230-s4ty52kb	115	18	management	management	NN
cord-258230-s4ty52kb	115	19	of	of	IN
cord-258230-s4ty52kb	115	20	arterial	arterial	JJ
cord-258230-s4ty52kb	115	21	hypertension	hypertension	NN
cord-258230-s4ty52kb	115	22	:	:	:
cord-258230-s4ty52kb	116	1	Indian	indian	JJ
cord-258230-s4ty52kb	116	2	perspective	perspective	NN
cord-258230-s4ty52kb	116	3	with	with	IN
cord-258230-s4ty52kb	116	4	a	a	DT
cord-258230-s4ty52kb	116	5	call	call	NN
cord-258230-s4ty52kb	116	6	for	for	IN
cord-258230-s4ty52kb	116	7	global	global	JJ
cord-258230-s4ty52kb	116	8	harmonization	harmonization	NN
cord-258230-s4ty52kb	116	9	Receptor	Receptor	NNP
cord-258230-s4ty52kb	116	10	recognition	recognition	NN
cord-258230-s4ty52kb	116	11	by	by	IN
cord-258230-s4ty52kb	116	12	the	the	DT
cord-258230-s4ty52kb	116	13	novel	novel	JJ
cord-258230-s4ty52kb	116	14	coronavirus	coronavirus	NN
cord-258230-s4ty52kb	116	15	from	from	IN
cord-258230-s4ty52kb	116	16	Wuhan	Wuhan	NNP
cord-258230-s4ty52kb	116	17	:	:	:
cord-258230-s4ty52kb	116	18	an	an	DT
cord-258230-s4ty52kb	116	19	analysis	analysis	NN
cord-258230-s4ty52kb	116	20	based	base	VBN
cord-258230-s4ty52kb	116	21	on	on	IN
cord-258230-s4ty52kb	116	22	decade	decade	NN
cord-258230-s4ty52kb	116	23	-	-	HYPH
cord-258230-s4ty52kb	116	24	long	long	JJ
cord-258230-s4ty52kb	116	25	structural	structural	JJ
cord-258230-s4ty52kb	116	26	studies	study	NNS
cord-258230-s4ty52kb	116	27	of	of	IN
cord-258230-s4ty52kb	116	28	SARS	SARS	NNP
cord-258230-s4ty52kb	116	29	coronavirus	coronavirus	NN
cord-258230-s4ty52kb	116	30	Risks	risk	NNS
cord-258230-s4ty52kb	116	31	of	of	IN
cord-258230-s4ty52kb	116	32	ACE	ace	NN
cord-258230-s4ty52kb	116	33	inhibitor	inhibitor	NN
cord-258230-s4ty52kb	116	34	and	and	CC
cord-258230-s4ty52kb	116	35	ARB	ARB	NNP
cord-258230-s4ty52kb	116	36	usage	usage	NN
cord-258230-s4ty52kb	116	37	in	in	IN
cord-258230-s4ty52kb	116	38	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	116	39	:	:	:
cord-258230-s4ty52kb	116	40	evaluating	evaluate	VBG
cord-258230-s4ty52kb	116	41	the	the	DT
cord-258230-s4ty52kb	116	42	evidence	evidence	NN
cord-258230-s4ty52kb	116	43	Position	Position	NNP
cord-258230-s4ty52kb	116	44	Statement	Statement	NNP
cord-258230-s4ty52kb	116	45	of	of	IN
cord-258230-s4ty52kb	116	46	the	the	DT
cord-258230-s4ty52kb	116	47	ESC	ESC	NNP
cord-258230-s4ty52kb	116	48	Council	Council	NNP
cord-258230-s4ty52kb	116	49	on	on	IN
cord-258230-s4ty52kb	116	50	Hypertension	Hypertension	NNP
cord-258230-s4ty52kb	116	51	on	on	IN
cord-258230-s4ty52kb	116	52	ACE	ACE	NNP
cord-258230-s4ty52kb	116	53	-	-	HYPH
cord-258230-s4ty52kb	116	54	Inhibitors	Inhibitors	NNP
cord-258230-s4ty52kb	116	55	and	and	CC
cord-258230-s4ty52kb	116	56	Angiotensin	Angiotensin	NNP
cord-258230-s4ty52kb	116	57	Receptor	Receptor	NNP
cord-258230-s4ty52kb	116	58	Blockers	Blockers	NNP
cord-258230-s4ty52kb	117	1	Should	Should	MD
cord-258230-s4ty52kb	117	2	patients	patient	NNS
cord-258230-s4ty52kb	117	3	receiving	receive	VBG
cord-258230-s4ty52kb	117	4	ACE	ace	NN
cord-258230-s4ty52kb	117	5	inhibitors	inhibitor	NNS
cord-258230-s4ty52kb	117	6	or	or	CC
cord-258230-s4ty52kb	117	7	angiotensin	angiotensin	NN
cord-258230-s4ty52kb	117	8	receptor	receptor	NN
cord-258230-s4ty52kb	117	9	blockers	blocker	NNS
cord-258230-s4ty52kb	117	10	be	be	VB
cord-258230-s4ty52kb	117	11	switched	switch	VBN
cord-258230-s4ty52kb	117	12	to	to	IN
cord-258230-s4ty52kb	117	13	other	other	JJ
cord-258230-s4ty52kb	117	14	antihypertensive	antihypertensive	JJ
cord-258230-s4ty52kb	117	15	drugs	drug	NNS
cord-258230-s4ty52kb	117	16	to	to	TO
cord-258230-s4ty52kb	117	17	prevent	prevent	VB
cord-258230-s4ty52kb	117	18	or	or	CC
cord-258230-s4ty52kb	117	19	improve	improve	VB
cord-258230-s4ty52kb	117	20	prognosis	prognosis	NN
cord-258230-s4ty52kb	117	21	of	of	IN
cord-258230-s4ty52kb	117	22	novel	novel	JJ
cord-258230-s4ty52kb	117	23	coronavirus	coronavirus	NN
cord-258230-s4ty52kb	117	24	disease	disease	NN
cord-258230-s4ty52kb	117	25	2019	2019	CD
cord-258230-s4ty52kb	117	26	(	(	-LRB-
cord-258230-s4ty52kb	117	27	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	117	28	)	)	-RRB-
cord-258230-s4ty52kb	117	29	?	?	.
cord-258230-s4ty52kb	118	1	The	the	DT
cord-258230-s4ty52kb	118	2	International	International	NNP
cord-258230-s4ty52kb	118	3	Society	Society	NNP
cord-258230-s4ty52kb	118	4	of	of	IN
cord-258230-s4ty52kb	118	5	Hypertension	Hypertension	NNP
cord-258230-s4ty52kb	118	6	.	.	.
cord-258230-s4ty52kb	119	1	A	a	DT
cord-258230-s4ty52kb	119	2	statement	statement	NN
cord-258230-s4ty52kb	119	3	from	from	IN
cord-258230-s4ty52kb	119	4	the	the	DT
cord-258230-s4ty52kb	119	5	International	International	NNP
cord-258230-s4ty52kb	119	6	Society	Society	NNP
cord-258230-s4ty52kb	119	7	of	of	IN
cord-258230-s4ty52kb	119	8	Hypertension	Hypertension	NNP
cord-258230-s4ty52kb	119	9	on	on	IN
cord-258230-s4ty52kb	119	10	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	119	11	HFSA	HFSA	NNP
cord-258230-s4ty52kb	119	12	/	/	SYM
cord-258230-s4ty52kb	119	13	ACC	ACC	NNP
cord-258230-s4ty52kb	120	1	/AHA	/AHA	,
cord-258230-s4ty52kb	120	2	Statement	statement	NN
cord-258230-s4ty52kb	121	1	Addresses	address	NNS
cord-258230-s4ty52kb	121	2	Concerns	concern	NNS
cord-258230-s4ty52kb	121	3	Re	re	IN
cord-258230-s4ty52kb	121	4	:	:	:
cord-258230-s4ty52kb	121	5	Using	use	VBG
cord-258230-s4ty52kb	121	6	RAAS	RAAS	NNP
cord-258230-s4ty52kb	121	7	Antagonists	Antagonists	NNPS
cord-258230-s4ty52kb	121	8	in	in	IN
cord-258230-s4ty52kb	121	9	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	121	10	-American	-American	NNP
cord-258230-s4ty52kb	121	11	College	College	NNP
cord-258230-s4ty52kb	121	12	of	of	IN
cord-258230-s4ty52kb	121	13	Cardiology	Cardiology	NNP
cord-258230-s4ty52kb	122	1	The	the	DT
cord-258230-s4ty52kb	122	2	Newcastle	Newcastle	NNP
cord-258230-s4ty52kb	122	3	-	-	HYPH
cord-258230-s4ty52kb	122	4	Ottawa	Ottawa	NNP
cord-258230-s4ty52kb	122	5	Scale	Scale	NNP
cord-258230-s4ty52kb	122	6	(	(	-LRB-
cord-258230-s4ty52kb	122	7	NOS	NOS	NNP
cord-258230-s4ty52kb	122	8	)	)	-RRB-
cord-258230-s4ty52kb	122	9	for	for	IN
cord-258230-s4ty52kb	122	10	assessing	assess	VBG
cord-258230-s4ty52kb	122	11	the	the	DT
cord-258230-s4ty52kb	122	12	quality	quality	NN
cord-258230-s4ty52kb	122	13	of	of	IN
cord-258230-s4ty52kb	122	14	nonrandomised	nonrandomise	VBN
cord-258230-s4ty52kb	122	15	studies	study	NNS
cord-258230-s4ty52kb	122	16	in	in	IN
cord-258230-s4ty52kb	122	17	meta	meta	NNP
cord-258230-s4ty52kb	122	18	-	-	HYPH
cord-258230-s4ty52kb	122	19	analyses	analysis	NNS
cord-258230-s4ty52kb	123	1	Renin	renin	NN
cord-258230-s4ty52kb	123	2	-	-	HYPH
cord-258230-s4ty52kb	123	3	angiotensin	angiotensin	NN
cord-258230-s4ty52kb	123	4	system	system	NN
cord-258230-s4ty52kb	123	5	inhibitors	inhibitor	NNS
cord-258230-s4ty52kb	123	6	improve	improve	VBP
cord-258230-s4ty52kb	123	7	the	the	DT
cord-258230-s4ty52kb	123	8	clinical	clinical	JJ
cord-258230-s4ty52kb	123	9	outcomes	outcome	NNS
cord-258230-s4ty52kb	123	10	of	of	IN
cord-258230-s4ty52kb	123	11	COVID-19	covid-19	JJ
cord-258230-s4ty52kb	123	12	patients	patient	NNS
cord-258230-s4ty52kb	123	13	with	with	IN
cord-258230-s4ty52kb	123	14	hypertension	hypertension	NN
cord-258230-s4ty52kb	124	1	Presenting	present	VBG
cord-258230-s4ty52kb	124	2	characteristics	characteristic	NNS
cord-258230-s4ty52kb	124	3	,	,	,
cord-258230-s4ty52kb	124	4	comorbidities	comorbiditie	NNS
cord-258230-s4ty52kb	124	5	,	,	,
cord-258230-s4ty52kb	124	6	and	and	CC
cord-258230-s4ty52kb	124	7	outcomes	outcome	NNS
cord-258230-s4ty52kb	124	8	among	among	IN
cord-258230-s4ty52kb	124	9	5700	5700	CD
cord-258230-s4ty52kb	124	10	patients	patient	NNS
cord-258230-s4ty52kb	124	11	hospitalized	hospitalize	VBN
cord-258230-s4ty52kb	124	12	with	with	IN
cord-258230-s4ty52kb	124	13	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	124	14	in	in	IN
cord-258230-s4ty52kb	124	15	the	the	DT
cord-258230-s4ty52kb	124	16	New	New	NNP
cord-258230-s4ty52kb	124	17	York	York	NNP
cord-258230-s4ty52kb	124	18	City	City	NNP
cord-258230-s4ty52kb	124	19	area	area	NN
cord-258230-s4ty52kb	124	20	Role	role	NN
cord-258230-s4ty52kb	124	21	of	of	IN
cord-258230-s4ty52kb	124	22	drugs	drug	NNS
cord-258230-s4ty52kb	124	23	affecting	affect	VBG
cord-258230-s4ty52kb	124	24	the	the	DT
cord-258230-s4ty52kb	124	25	renin	renin	NN
cord-258230-s4ty52kb	124	26	-	-	HYPH
cord-258230-s4ty52kb	124	27	angiotensin	angiotensin	NN
cord-258230-s4ty52kb	124	28	-	-	HYPH
cord-258230-s4ty52kb	124	29	aldosterone	aldosterone	NN
cord-258230-s4ty52kb	124	30	system	system	NN
cord-258230-s4ty52kb	124	31	on	on	IN
cord-258230-s4ty52kb	124	32	susceptibility	susceptibility	NN
cord-258230-s4ty52kb	124	33	and	and	CC
cord-258230-s4ty52kb	124	34	severity	severity	NN
cord-258230-s4ty52kb	124	35	of	of	IN
cord-258230-s4ty52kb	124	36	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	124	37	:	:	:
cord-258230-s4ty52kb	124	38	a	a	DT
cord-258230-s4ty52kb	124	39	large	large	JJ
cord-258230-s4ty52kb	124	40	case	case	NN
cord-258230-s4ty52kb	124	41	-	-	HYPH
cord-258230-s4ty52kb	124	42	control	control	NN
cord-258230-s4ty52kb	124	43	study	study	NN
cord-258230-s4ty52kb	124	44	from	from	IN
cord-258230-s4ty52kb	124	45	Zheijang	Zheijang	NNP
cord-258230-s4ty52kb	124	46	Province	Province	NNP
cord-258230-s4ty52kb	124	47	,	,	,
cord-258230-s4ty52kb	124	48	China	China	NNP
cord-258230-s4ty52kb	124	49	Renin	Renin	NNP
cord-258230-s4ty52kb	124	50	-	-	HYPH
cord-258230-s4ty52kb	124	51	angiotensin	angiotensin	NN
cord-258230-s4ty52kb	124	52	-	-	HYPH
cord-258230-s4ty52kb	124	53	aldosterone	aldosterone	NN
cord-258230-s4ty52kb	124	54	system	system	NN
cord-258230-s4ty52kb	124	55	blockers	blocker	NNS
cord-258230-s4ty52kb	124	56	and	and	CC
cord-258230-s4ty52kb	124	57	the	the	DT
cord-258230-s4ty52kb	124	58	risk	risk	NN
cord-258230-s4ty52kb	124	59	of	of	IN
cord-258230-s4ty52kb	124	60	Covid-19	Covid-19	NNP
cord-258230-s4ty52kb	124	61	Cardiovascular	Cardiovascular	NNP
cord-258230-s4ty52kb	124	62	disease	disease	NN
cord-258230-s4ty52kb	124	63	,	,	,
cord-258230-s4ty52kb	124	64	drug	drug	NN
cord-258230-s4ty52kb	124	65	therapy	therapy	NN
cord-258230-s4ty52kb	124	66	,	,	,
cord-258230-s4ty52kb	124	67	and	and	CC
cord-258230-s4ty52kb	124	68	mortality	mortality	NN
cord-258230-s4ty52kb	124	69	in	in	IN
cord-258230-s4ty52kb	124	70	Covid-19	Covid-19	NNP
cord-258230-s4ty52kb	124	71	Renin	Renin	NNP
cord-258230-s4ty52kb	124	72	-	-	HYPH
cord-258230-s4ty52kb	124	73	angiotensin	angiotensin	NN
cord-258230-s4ty52kb	124	74	-	-	HYPH
cord-258230-s4ty52kb	124	75	aldosterone	aldosterone	NN
cord-258230-s4ty52kb	124	76	system	system	NN
cord-258230-s4ty52kb	124	77	inhibitors	inhibitor	NNS
cord-258230-s4ty52kb	124	78	and	and	CC
cord-258230-s4ty52kb	124	79	risk	risk	NN
cord-258230-s4ty52kb	124	80	of	of	IN
cord-258230-s4ty52kb	124	81	Covid-19	Covid-19	NNP
cord-258230-s4ty52kb	124	82	Amouyel	Amouyel	NNP
cord-258230-s4ty52kb	124	83	P	P	NNP
cord-258230-s4ty52kb	124	84	,	,	,
cord-258230-s4ty52kb	124	85	on	on	IN
cord-258230-s4ty52kb	124	86	behalf	behalf	NN
cord-258230-s4ty52kb	124	87	of	of	IN
cord-258230-s4ty52kb	124	88	the	the	DT
cord-258230-s4ty52kb	124	89	Lille	Lille	NNP
cord-258230-s4ty52kb	124	90	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	124	91	study	study	NN
cord-258230-s4ty52kb	124	92	group	group	NN
cord-258230-s4ty52kb	124	93	.	.	.
cord-258230-s4ty52kb	125	1	ACE	ACE	NNP
cord-258230-s4ty52kb	125	2	inhibitors	inhibitor	NNS
cord-258230-s4ty52kb	125	3	,	,	,
cord-258230-s4ty52kb	125	4	AT1	at1	NN
cord-258230-s4ty52kb	125	5	receptor	receptor	NN
cord-258230-s4ty52kb	125	6	blockers	blocker	NNS
cord-258230-s4ty52kb	125	7	and	and	CC
cord-258230-s4ty52kb	125	8	COVID-19	covid-19	VB
cord-258230-s4ty52kb	125	9	:	:	:
cord-258230-s4ty52kb	125	10	clinical	clinical	JJ
cord-258230-s4ty52kb	125	11	epidemiology	epidemiology	NN
cord-258230-s4ty52kb	125	12	evidences	evidence	NNS
cord-258230-s4ty52kb	125	13	for	for	IN
cord-258230-s4ty52kb	125	14	a	a	DT
cord-258230-s4ty52kb	125	15	continuation	continuation	NN
cord-258230-s4ty52kb	125	16	of	of	IN
cord-258230-s4ty52kb	125	17	treatments	treatment	NNS
cord-258230-s4ty52kb	125	18	.	.	.
cord-258230-s4ty52kb	126	1	The	the	DT
cord-258230-s4ty52kb	126	2	ACER	ACER	NNP
cord-258230-s4ty52kb	126	3	-	-	HYPH
cord-258230-s4ty52kb	126	4	COVID	COVID	NNP
cord-258230-s4ty52kb	126	5	study	study	NN
cord-258230-s4ty52kb	126	6	Association	Association	NNP
cord-258230-s4ty52kb	126	7	of	of	IN
cord-258230-s4ty52kb	126	8	inpatient	inpatient	JJ
cord-258230-s4ty52kb	126	9	use	use	NN
cord-258230-s4ty52kb	126	10	of	of	IN
cord-258230-s4ty52kb	126	11	angiotensin	angiotensin	NN
cord-258230-s4ty52kb	126	12	converting	convert	VBG
cord-258230-s4ty52kb	126	13	enzyme	enzyme	NN
cord-258230-s4ty52kb	126	14	inhibitors	inhibitor	NNS
cord-258230-s4ty52kb	126	15	and	and	CC
cord-258230-s4ty52kb	126	16	angiotensin	angiotensin	NN
cord-258230-s4ty52kb	126	17	II	ii	CD
cord-258230-s4ty52kb	126	18	receptor	receptor	NN
cord-258230-s4ty52kb	126	19	blockers	blocker	NNS
cord-258230-s4ty52kb	126	20	with	with	IN
cord-258230-s4ty52kb	126	21	mortality	mortality	NN
cord-258230-s4ty52kb	126	22	among	among	IN
cord-258230-s4ty52kb	126	23	patients	patient	NNS
cord-258230-s4ty52kb	126	24	with	with	IN
cord-258230-s4ty52kb	126	25	hypertension	hypertension	NN
cord-258230-s4ty52kb	126	26	hospitalized	hospitalize	VBN
cord-258230-s4ty52kb	126	27	with	with	IN
cord-258230-s4ty52kb	126	28	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	126	29	Association	Association	NNP
cord-258230-s4ty52kb	126	30	of	of	IN
cord-258230-s4ty52kb	126	31	renin	renin	NN
cord-258230-s4ty52kb	126	32	-	-	HYPH
cord-258230-s4ty52kb	126	33	angiotensin	angiotensin	NN
cord-258230-s4ty52kb	126	34	system	system	NN
cord-258230-s4ty52kb	126	35	inhibitors	inhibitor	NNS
cord-258230-s4ty52kb	126	36	with	with	IN
cord-258230-s4ty52kb	126	37	severity	severity	NN
cord-258230-s4ty52kb	126	38	or	or	CC
cord-258230-s4ty52kb	126	39	risk	risk	NN
cord-258230-s4ty52kb	126	40	of	of	IN
cord-258230-s4ty52kb	126	41	death	death	NN
cord-258230-s4ty52kb	126	42	in	in	IN
cord-258230-s4ty52kb	126	43	patients	patient	NNS
cord-258230-s4ty52kb	126	44	with	with	IN
cord-258230-s4ty52kb	126	45	hypertension	hypertension	NN
cord-258230-s4ty52kb	126	46	hospitalized	hospitalize	VBN
cord-258230-s4ty52kb	126	47	for	for	IN
cord-258230-s4ty52kb	126	48	coronavirus	coronavirus	NN
cord-258230-s4ty52kb	126	49	disease	disease	NN
cord-258230-s4ty52kb	126	50	2019	2019	CD
cord-258230-s4ty52kb	126	51	(	(	-LRB-
cord-258230-s4ty52kb	126	52	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	126	53	)	)	-RRB-
cord-258230-s4ty52kb	126	54	infection	infection	NN
cord-258230-s4ty52kb	126	55	in	in	IN
cord-258230-s4ty52kb	126	56	Wuhan	Wuhan	NNP
cord-258230-s4ty52kb	126	57	,	,	,
cord-258230-s4ty52kb	126	58	China	China	NNP
cord-258230-s4ty52kb	126	59	Anti	Anti	NNP
cord-258230-s4ty52kb	126	60	-	-	JJ
cord-258230-s4ty52kb	126	61	hypertensive	hypertensive	JJ
cord-258230-s4ty52kb	126	62	angiotensin	angiotensin	NN
cord-258230-s4ty52kb	126	63	II	II	NNP
cord-258230-s4ty52kb	126	64	receptor	receptor	NN
cord-258230-s4ty52kb	126	65	blockers	blocker	NNS
cord-258230-s4ty52kb	126	66	associated	associate	VBN
cord-258230-s4ty52kb	126	67	to	to	IN
cord-258230-s4ty52kb	126	68	mitigation	mitigation	NN
cord-258230-s4ty52kb	126	69	of	of	IN
cord-258230-s4ty52kb	126	70	disease	disease	NN
cord-258230-s4ty52kb	126	71	severity	severity	NN
cord-258230-s4ty52kb	126	72	in	in	IN
cord-258230-s4ty52kb	126	73	elderly	elderly	JJ
cord-258230-s4ty52kb	126	74	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	126	75	patients	patient	NNS
cord-258230-s4ty52kb	126	76	COVID-19	covid-19	VBP
cord-258230-s4ty52kb	126	77	with	with	IN
cord-258230-s4ty52kb	126	78	different	different	JJ
cord-258230-s4ty52kb	126	79	severity	severity	NN
cord-258230-s4ty52kb	126	80	:	:	:
cord-258230-s4ty52kb	126	81	a	a	DT
cord-258230-s4ty52kb	126	82	multi	multi	JJ
cord-258230-s4ty52kb	126	83	-	-	JJ
cord-258230-s4ty52kb	126	84	center	center	JJ
cord-258230-s4ty52kb	126	85	study	study	NN
cord-258230-s4ty52kb	126	86	of	of	IN
cord-258230-s4ty52kb	126	87	clinical	clinical	JJ
cord-258230-s4ty52kb	126	88	features	feature	NNS
cord-258230-s4ty52kb	126	89	.	.	.
cord-258230-s4ty52kb	127	1	COVID-19	covid-19	VB
cord-258230-s4ty52kb	127	2	with	with	IN
cord-258230-s4ty52kb	127	3	different	different	JJ
cord-258230-s4ty52kb	127	4	severity	severity	NN
cord-258230-s4ty52kb	127	5	:	:	:
cord-258230-s4ty52kb	127	6	a	a	DT
cord-258230-s4ty52kb	127	7	multi	multi	JJ
cord-258230-s4ty52kb	127	8	-	-	JJ
cord-258230-s4ty52kb	127	9	center	center	JJ
cord-258230-s4ty52kb	127	10	study	study	NN
cord-258230-s4ty52kb	127	11	of	of	IN
cord-258230-s4ty52kb	127	12	clinical	clinical	JJ
cord-258230-s4ty52kb	127	13	features	feature	VBZ
cord-258230-s4ty52kb	127	14	Cardiovascular	cardiovascular	JJ
cord-258230-s4ty52kb	127	15	implications	implication	NNS
cord-258230-s4ty52kb	127	16	of	of	IN
cord-258230-s4ty52kb	127	17	fatal	fatal	JJ
cord-258230-s4ty52kb	127	18	outcomes	outcome	NNS
cord-258230-s4ty52kb	127	19	of	of	IN
cord-258230-s4ty52kb	127	20	patients	patient	NNS
cord-258230-s4ty52kb	127	21	with	with	IN
cord-258230-s4ty52kb	127	22	coronavirus	coronavirus	NN
cord-258230-s4ty52kb	127	23	disease	disease	NN
cord-258230-s4ty52kb	127	24	2019	2019	CD
cord-258230-s4ty52kb	127	25	(	(	-LRB-
cord-258230-s4ty52kb	127	26	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	127	27	)	)	-RRB-
cord-258230-s4ty52kb	127	28	Treatment	treatment	NN
cord-258230-s4ty52kb	127	29	with	with	IN
cord-258230-s4ty52kb	127	30	ACE	ace	NN
cord-258230-s4ty52kb	127	31	-	-	HYPH
cord-258230-s4ty52kb	127	32	inhibitors	inhibitor	NNS
cord-258230-s4ty52kb	127	33	is	be	VBZ
cord-258230-s4ty52kb	127	34	associated	associate	VBN
cord-258230-s4ty52kb	127	35	with	with	IN
cord-258230-s4ty52kb	127	36	less	less	RBR
cord-258230-s4ty52kb	127	37	severe	severe	JJ
cord-258230-s4ty52kb	127	38	disease	disease	NN
cord-258230-s4ty52kb	127	39	with	with	IN
cord-258230-s4ty52kb	127	40	SARS	SARS	NNP
cord-258230-s4ty52kb	127	41	-	-	HYPH
cord-258230-s4ty52kb	127	42	Covid-19	Covid-19	NNP
cord-258230-s4ty52kb	127	43	infection	infection	NN
cord-258230-s4ty52kb	127	44	in	in	IN
cord-258230-s4ty52kb	127	45	a	a	DT
cord-258230-s4ty52kb	127	46	multi	multi	JJ
cord-258230-s4ty52kb	127	47	-	-	JJ
cord-258230-s4ty52kb	127	48	site	site	NN
cord-258230-s4ty52kb	127	49	UK	UK	NNP
cord-258230-s4ty52kb	127	50	acute	acute	NN
cord-258230-s4ty52kb	127	51	Hospital	Hospital	NNP
cord-258230-s4ty52kb	127	52	Trust	Trust	NNP
cord-258230-s4ty52kb	127	53	Effects	effect	NNS
cord-258230-s4ty52kb	127	54	of	of	IN
cord-258230-s4ty52kb	127	55	ARBs	arb	NNS
cord-258230-s4ty52kb	127	56	and	and	CC
cord-258230-s4ty52kb	127	57	ACEIs	acei	NNS
cord-258230-s4ty52kb	127	58	on	on	IN
cord-258230-s4ty52kb	127	59	virus	virus	NN
cord-258230-s4ty52kb	127	60	infection	infection	NN
cord-258230-s4ty52kb	127	61	,	,	,
cord-258230-s4ty52kb	127	62	inflammatory	inflammatory	JJ
cord-258230-s4ty52kb	127	63	status	status	NN
cord-258230-s4ty52kb	127	64	and	and	CC
cord-258230-s4ty52kb	127	65	clinical	clinical	JJ
cord-258230-s4ty52kb	127	66	outcomes	outcome	NNS
cord-258230-s4ty52kb	127	67	in	in	IN
cord-258230-s4ty52kb	127	68	COVID-19	covid-19	JJ
cord-258230-s4ty52kb	127	69	patients	patient	NNS
cord-258230-s4ty52kb	127	70	with	with	IN
cord-258230-s4ty52kb	127	71	hypertension	hypertension	NN
cord-258230-s4ty52kb	127	72	:	:	:
cord-258230-s4ty52kb	127	73	a	a	DT
cord-258230-s4ty52kb	127	74	single	single	JJ
cord-258230-s4ty52kb	127	75	center	center	NN
cord-258230-s4ty52kb	127	76	retrospective	retrospective	JJ
cord-258230-s4ty52kb	127	77	study	study	NN
cord-258230-s4ty52kb	127	78	Hypertension	hypertension	NN
cord-258230-s4ty52kb	127	79	in	in	IN
cord-258230-s4ty52kb	127	80	patients	patient	NNS
cord-258230-s4ty52kb	127	81	hospitalized	hospitalize	VBN
cord-258230-s4ty52kb	127	82	with	with	IN
cord-258230-s4ty52kb	127	83	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	127	84	in	in	IN
cord-258230-s4ty52kb	127	85	Wuhan	Wuhan	NNP
cord-258230-s4ty52kb	127	86	,	,	,
cord-258230-s4ty52kb	127	87	China	China	NNP
cord-258230-s4ty52kb	127	88	:	:	:
cord-258230-s4ty52kb	127	89	a	a	DT
cord-258230-s4ty52kb	127	90	singlecenter	singlecenter	JJ
cord-258230-s4ty52kb	127	91	retrospective	retrospective	JJ
cord-258230-s4ty52kb	127	92	observational	observational	JJ
cord-258230-s4ty52kb	127	93	study	study	NN
cord-258230-s4ty52kb	127	94	Hypertension	hypertension	NN
cord-258230-s4ty52kb	127	95	and	and	CC
cord-258230-s4ty52kb	127	96	renin	renin	NN
cord-258230-s4ty52kb	127	97	-	-	HYPH
cord-258230-s4ty52kb	127	98	angiotensin	angiotensin	NN
cord-258230-s4ty52kb	127	99	-	-	HYPH
cord-258230-s4ty52kb	127	100	aldosterone	aldosterone	NN
cord-258230-s4ty52kb	127	101	system	system	NN
cord-258230-s4ty52kb	127	102	inhibitors	inhibitor	NNS
cord-258230-s4ty52kb	127	103	in	in	IN
cord-258230-s4ty52kb	127	104	patients	patient	NNS
cord-258230-s4ty52kb	127	105	with	with	IN
cord-258230-s4ty52kb	127	106	Covid-19	Covid-19	NNP
cord-258230-s4ty52kb	127	107	Chinese	Chinese	NNP
cord-258230-s4ty52kb	127	108	Clinical	Clinical	NNP
cord-258230-s4ty52kb	127	109	Guidance	Guidance	NNP
cord-258230-s4ty52kb	127	110	for	for	IN
cord-258230-s4ty52kb	127	111	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	127	112	Pneumonia	Pneumonia	NNP
cord-258230-s4ty52kb	127	113	Diagnosis	Diagnosis	NNP
cord-258230-s4ty52kb	127	114	and	and	CC
cord-258230-s4ty52kb	127	115	Treatment	Treatment	NNP
cord-258230-s4ty52kb	127	116	Evaluating	evaluate	VBG
cord-258230-s4ty52kb	127	117	the	the	DT
cord-258230-s4ty52kb	127	118	effectiveness	effectiveness	NN
cord-258230-s4ty52kb	127	119	of	of	IN
cord-258230-s4ty52kb	127	120	social	social	JJ
cord-258230-s4ty52kb	127	121	distancing	distance	VBG
cord-258230-s4ty52kb	127	122	interventions	intervention	NNS
cord-258230-s4ty52kb	127	123	to	to	TO
cord-258230-s4ty52kb	127	124	delay	delay	VB
cord-258230-s4ty52kb	127	125	or	or	CC
cord-258230-s4ty52kb	127	126	flatten	flatten	VB
cord-258230-s4ty52kb	127	127	the	the	DT
cord-258230-s4ty52kb	127	128	epidemic	epidemic	NN
cord-258230-s4ty52kb	127	129	curve	curve	NN
cord-258230-s4ty52kb	127	130	of	of	IN
cord-258230-s4ty52kb	127	131	coronavirus	coronavirus	NN
cord-258230-s4ty52kb	127	132	disease	disease	NN
cord-258230-s4ty52kb	128	1	Pö	pö	NN
cord-258230-s4ty52kb	128	2	hlmann	hlmann	NN
cord-258230-s4ty52kb	128	3	S.	S.	NNP
cord-258230-s4ty52kb	128	4	SARS	SARS	NNP
cord-258230-s4ty52kb	128	5	-	-	HYPH
cord-258230-s4ty52kb	128	6	CoV-2	CoV-2	NNP
cord-258230-s4ty52kb	128	7	cell	cell	NN
cord-258230-s4ty52kb	128	8	entry	entry	NN
cord-258230-s4ty52kb	128	9	depends	depend	VBZ
cord-258230-s4ty52kb	128	10	on	on	IN
cord-258230-s4ty52kb	128	11	ACE2	ACE2	NNP
cord-258230-s4ty52kb	128	12	and	and	CC
cord-258230-s4ty52kb	128	13	TMPRSS2	TMPRSS2	NNP
cord-258230-s4ty52kb	128	14	and	and	CC
cord-258230-s4ty52kb	128	15	is	be	VBZ
cord-258230-s4ty52kb	128	16	blocked	block	VBN
cord-258230-s4ty52kb	128	17	by	by	IN
cord-258230-s4ty52kb	128	18	a	a	DT
cord-258230-s4ty52kb	128	19	clinically	clinically	RB
cord-258230-s4ty52kb	128	20	proven	prove	VBN
cord-258230-s4ty52kb	128	21	protease	protease	NN
cord-258230-s4ty52kb	128	22	inhibitor	inhibitor	NN
cord-258230-s4ty52kb	128	23	Outcomes	outcome	NNS
cord-258230-s4ty52kb	128	24	in	in	IN
cord-258230-s4ty52kb	128	25	patients	patient	NNS
cord-258230-s4ty52kb	128	26	with	with	IN
cord-258230-s4ty52kb	128	27	COVID-19	covid-19	JJ
cord-258230-s4ty52kb	128	28	infection	infection	NN
cord-258230-s4ty52kb	128	29	taking	take	VBG
cord-258230-s4ty52kb	128	30	ACEI	ACEI	NNP
cord-258230-s4ty52kb	128	31	/	/	SYM
cord-258230-s4ty52kb	128	32	ARB	ARB	NNP
cord-258230-s4ty52kb	129	1	Are	be	VBP
cord-258230-s4ty52kb	129	2	patients	patient	NNS
cord-258230-s4ty52kb	129	3	with	with	IN
cord-258230-s4ty52kb	129	4	hypertension	hypertension	NN
cord-258230-s4ty52kb	129	5	and	and	CC
cord-258230-s4ty52kb	129	6	diabetes	diabetes	NN
cord-258230-s4ty52kb	129	7	mellitus	mellitus	NN
cord-258230-s4ty52kb	129	8	at	at	IN
cord-258230-s4ty52kb	129	9	increased	increase	VBN
cord-258230-s4ty52kb	129	10	risk	risk	NN
cord-258230-s4ty52kb	129	11	for	for	IN
cord-258230-s4ty52kb	129	12	COVID-19	covid-19	JJ
cord-258230-s4ty52kb	129	13	infection	infection	NN
cord-258230-s4ty52kb	129	14	?	?	.
cord-258230-s4ty52kb	130	1	Losartan	Losartan	NNP
cord-258230-s4ty52kb	130	2	for	for	IN
cord-258230-s4ty52kb	130	3	Patients	patient	NNS
cord-258230-s4ty52kb	130	4	With	with	IN
cord-258230-s4ty52kb	131	1	COVID-19	covid-19	VB
cord-258230-s4ty52kb	132	1	Not	not	RB
cord-258230-s4ty52kb	132	2	Requiring	require	VBG
cord-258230-s4ty52kb	132	3	Hospitalization	hospitalization	NN
cord-258230-s4ty52kb	133	1	-Full	-Full	.
cord-258230-s4ty52kb	134	1	Text	Text	NNP
cord-258230-s4ty52kb	134	2	View	View	NNP
cord-258230-s4ty52kb	135	1	-ClinicalTrials	-ClinicalTrials	.
cord-258230-s4ty52kb	136	1	Losartan	Losartan	NNP
cord-258230-s4ty52kb	136	2	for	for	IN
cord-258230-s4ty52kb	136	3	Patients	patient	NNS
cord-258230-s4ty52kb	136	4	With	with	IN
cord-258230-s4ty52kb	136	5	COVID-19	COVID-19	NNP
cord-258230-s4ty52kb	137	1	Requiring	require	VBG
cord-258230-s4ty52kb	137	2	Hospitalization	hospitalization	NN
cord-258230-s4ty52kb	138	1	-Full	-Full	.
cord-258230-s4ty52kb	139	1	Text	Text	NNP
cord-258230-s4ty52kb	139	2	View	View	NNP
cord-258230-s4ty52kb	140	1	-ClinicalTrials	-ClinicalTrials	.
cord-258230-s4ty52kb	141	1	Data	datum	NNS
cord-258230-s4ty52kb	141	2	availability	availability	NN
cord-258230-s4ty52kb	141	3	statement	statement	NN
cord-258230-s4ty52kb	141	4	:	:	:
cord-258230-s4ty52kb	142	1	The	the	DT
cord-258230-s4ty52kb	142	2	data	datum	NNS
cord-258230-s4ty52kb	142	3	underlying	underlie	VBG
cord-258230-s4ty52kb	142	4	this	this	DT
cord-258230-s4ty52kb	142	5	article	article	NN
cord-258230-s4ty52kb	142	6	are	be	VBP
cord-258230-s4ty52kb	142	7	available	available	JJ
cord-258230-s4ty52kb	142	8	in	in	IN
cord-258230-s4ty52kb	142	9	the	the	DT
cord-258230-s4ty52kb	142	10	article	article	NN
cord-258230-s4ty52kb	142	11	and	and	CC
cord-258230-s4ty52kb	142	12	in	in	IN
cord-258230-s4ty52kb	142	13	its	-PRON-	PRP$
cord-258230-s4ty52kb	142	14	online	online	JJ
cord-258230-s4ty52kb	142	15	Supplementary	supplementary	JJ
cord-258230-s4ty52kb	142	16	material	material	NN
cord-258230-s4ty52kb	142	17	.	.	.